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11  Introduction 
1.1  Nanomedicine in drug delivery 
A challenge in conventional therapy is the non-selective delivery of toxic agents to both 
normal and diseased tissue. Sophisticated drug delivery aims to develop selective and 
specific delivery of therapeutic and diagnostic agents in order to minimize systemic 
side-effects. To achieve this goal, knowledge and experience from nanotechnology, 
advanced polymer chemistry, and optical engineering are being brought together.
The term nanomedicine has been given a variety of definitions.1-3 Here, we define 
nanomedicine as nanoscale or nanostructured materials in medicine that by their 
structure have unique medical effects.2 Nanomedicine differ from small-molecule drugs 
and includes macromolecular therapeutic agents, such as monoclonal antibodies, 
liposomes, polymers, and dendrimers. Nanomedicine may have inherent diagnostic 
properties themselves, or they may protect, induce target-specificity or -selectivity, or 
overcome drug solubility issues by serving as vehicles for therapeutic and diagnostic 
agents.3
In this work we focus on drug delivery after intravenous administration. For successful 
drug delivery, the therapeutic agents must be transported across the vascular wall and 
through the extracellular matrix (ECM) toward the target cells. If the target is the cell 
nucleus, the therapeutic agents must further penetrate the cell membrane and travel 
through the intracellular environment to the nucleus. Each of these steps constitutes a 
barrier to drug delivery. In cancer therapy, macromolecular therapeutic agents are of 
great interest due to their selectivity or specificity for tumor tissue after injection. 
However, only a minor fraction of the injected macromolecules has been shown to 
accumulate in tumor tissue, and the distribution is heterogeneous.4-6 The biodistribution 
of the therapeutic agents is determined by the microvascular network, perfusion, 
permeability across the blood vessel wall, and diffusion through the extracellular matrix 
to the target cells. It is therefore important to develop suitable methods for 
characterizing transport in the vascular, interstitial, and cellular compartments. 
21.2 Tumor characteristics 
Because of inadequate blood perfusion, tumors are characterized by a range of structural 
and functional abnormalities which form barriers to the delivery of nanomedicine7,8 The 
vascular architecture is tortuous, irregular, and highly heterogeneous (Fig. 1).7,9 The 
endothelial lining of the tumor vessel wall is incomplete or missing, which results in 
leaky tumor vessels. Due to the chaotic, permeable vascular network combined with a 
high microvascular pressure (MVP), the interstitial fluid pressure (IFP) in tumors is 
elevated. This diminishes the pressure gradient and thereby the fluid flow from the 
vessels to the interstitium.5,10-12 The absence of an anatomically well-defined 
functioning lymphatic network is also characteristic of tumors. Excess fluid which is not 
reabsorbed into the microvascular network may thus ooze out of the tumor periphery 
and be collected by the lymphatic vessels of the surrounding normal tissue, thereby 
aiding the metastatic process.13
Figure 1. 3D reconstruction of blood vessels in mice showing the abnormal architecture of the tumor 
microenvironment characterized by tortuous vasculature (left) compared to the well-organized parallel 
blood vessels in normal tissue (right).
3The enhanced vascular permeability is of great interest in cancer-selective therapy 
because the leaky capillaries favor the transport of therapeutic agents across the blood 
vessel wall.14 It is mainly macromolecules that are able to utilize this hyperpermeability 
and discriminate between normal and tumor vessels, and not low molecular weight 
compounds like most conventional anticancer agents. Macromolecules also show 
slower clearance from tumors and inflammatory tissue compared to low molecular 
weight substances, which are not retained but diffuse back into the circulating blood, 
and they have a longer plasma half-time which enhances the therapy efficacy.15-17 The 
vascular permeability is shown to be dependent on the molecular weight and charge of 
the tracer,18,19 as well as the tumor type.20-22
Angiogenesis is essential for formation of new blood vessels and is an important step in 
tumor growth. The number of branching points is an estimate of the number of neo-
formed vessels. This parameter, called the fork density, has previously been shown to 
correlate with angiogenetic activity.23 Early quantitative studies showed that the 
vascular volume predicted growth rate and stage of tumors, and slightly higher vascular 
density has been reported in tumors compared to normal tissue.24-27 However, both 
vascular volume and density are dependent on tumor type.28,29 Fractal analysis describes 
non-Euclidean structural properties like self-similarity and tortuousity.30,31 The fractal 
dimension of the microvasculature may be used to distinguish between the architecture 
of tumor and normal tissue, and may predict necrosis, survival, and tumor grade.32,33
The interstitium, defined as the extracellular space exclusive of the vascular space, 
consists of a collagen and elastic fiber network embedded in a hydrophilic gel of 
glycosaminoglycans and proteoglycans. The interstitium of tumors has several 
abnormal characteristics. The large interstitial space and low concentrations of 
polysaccharides may facilitate transport of therapeutic agents.13,29 On the other hand, the 
high IFP in the inner parts of tumors induces an outward pressure gradient that obstructs 
the penetration of therapeutic agents.9
1.3 Molecular transport mechanisms in tissue 
Tissue can be divided into the vascular, interstitial, and cellular subcompartments. 
Transport of molecules in and between these compartments depends on the 
microenvironment as well as molecular parameters, like size, charge, and structure of 
the drug and its carrier. Because of the high IFP in tumors, transvascular and interstitial 
transport is largely dependent on diffusion. 
41.3.1 Diffusion and convection 
The thermal fluctuations of a particle suspended in a fluid cause it to constantly collide 
with surrounding particles. This random movement induces a net transport of the 
particles from an area of high concentration to an area of lower concentration. The one-
dimensional diffusion flux DJ  is proportional to the concentration gradient C / xs s ,  as 
described by  Fick’s law 
D
CJ D
x
 ¬s ­= ­ ­ ®s
 (1) 
where D  is the macroscopic diffusion coefficient, C the particle concentration, and x
the position coordinate.
Fick’s law leads to the diffusion equation, whose solution describes the mean square 
displacement of a freely diffusing particle by 
( )2 6x t Dt=  (2) 
The mean square displacement is thus proportional to the square root of the elapsed 
time t and the diffusion coefficient. Diffusion is a slow process for large particles, and 
the diffusion coefficient is related to the hydrodynamic radius R of the diffusing particle 
by the Stokes-Einstein relation 
6
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where Bk  is the Boltzmann constant, T is the temperature and I  is the viscosity of the 
solvent.
In complex media, the mean square displacement is expected to obey a power law 
( )2 6x t tB(=  (4) 
where (  is a constant independent of time. If the exponent 1Bv  the diffusion is 
anomalous, and anomalous subdiffusion is given by 1B< . For anomalous diffusion the 
diffusion coefficient depends on the timescale, or equivalently the length scale, of the 
measurement and can be written as34
1D( t ) tB( =  (5) 
5Convection is fluid flow from areas of high pressure to areas of low pressure. The 
convective flux can be described by35
CJ Cv=  (6) 
where v  is the velocity of the dissolved particles and the solvent. 
1.3.2 Transvascular transport 
The transport of a solute across the vessel wall and into the interstitium occurs by 
diffusion and convection. The total transvascular flow of solute TJ  can be described by 
the Staverman-Kedem-Katchalsky equation
( ) ( ) ( )
1 v iT v i F F
v
c cJ PA c c J
ln c / c
=  + T  (7) 
where P is the diffusive permeability, A the surface area of the vessel, vc  and ic  the 
plasma and interstitial concentrations of the solute, respectively, FJ  the net fluid flow 
across the vessel wall, and ( )1TF  the coupling between fluid and solute transport.14
According to Starling's hypothesis, net fluid flow across a vessel wall is given by 
( ) ( )F P v iJ L A MVP IFP  ¯=  T Q Q¢ ±  (8) 
where FJ  is the volume flow of fluid across the vessel wall, PL  the hydraulic 
conductivity of the vessel, MVP and IFP the vascular and interstitial fluid pressures, T
the osmotic reflection coefficient, and vQ  and iQ   the colloid-osmotic pressures in 
plasma and interstitial fluid.36 Due to the elevated IFP in tumors, FJ  is extremely low 
and the diffusive term of Eq. (7) is the dominating. 
1.3.3 Interstitial transport 
The transport of molecules in the interstitium is also governed by diffusion and 
convection. One-dimensional interstitial transport JI can be described as the sum of a 
diffusive and a convective term as 
I F
C pJ D CR K
x x
s s= 
s s
 (9) 
6where the diffusive term is identical to Eq. 1 and the convective term is described by the  
retardation factor FR , the tissue hydraulic conductivity K  for convective flow of solvent 
through the medium, and the pressure gradient p / xs s .13
1.3.4 Intracellular transport and gene delivery 
The intracellular pathway for nanomedicine constitutes a complex journey. The 
therapeutic agents must be transported through the cell membrane by endocytosis and 
survive in the hostile intracellular environment as they travel to the cell nucleus. In the 
field of gene delivery, research aims to develop gene vectors that facilitate transport and 
protect the DNA from degradation. Out of non-viral gene delivery vectors, cationic 
polymers are one of the major types. Because of their permanent cationic charge, 
polycations spontaneously self-assembly with the negatively charged DNA and form 
compacted DNA-polycation complexes (polyplexes). The complexation reduces the 
extensive size of the DNA molecule and masks its negative charges, and thus aids the 
transport through the cell membrane and protects the DNA against nuclease 
degradation.37,38 The condensation behavior depends on the length of the DNA, the 
structure of the polycation, and the mixing ratio.39,40
Polyplexes are internalized by endocytosis and delivered to endosomes and 
subsequently to lysosomes. Further delivery of DNA to the nucleus requires escape of 
the polyplex from endosomes or lysosomes, DNA/polymer dissociation, cytoplasmic 
DNA diffusion, and nuclear uptake.41-45 Polymer-based gene transfer requires a balance 
between sufficient DNA protection and intracellular DNA release, which reflects the 
degree of interaction between the polycation and the DNA.46-48 Inside the nucleus the 
exogenous genes are transcribed. A schematic drawing of the gene delivery pathway of 
polyplexes is shown in Fig. 2.
7Figure 2. After binding to the cell membrane, the intracellular pathway of a polyplex can be represented 
by five distinct biophysical states (S): bound to cell membrane (S=M), inside endosomes (S=E), inside 
lysosomes (S=L), in the cytoplasm (S=C), and unpacked plasmids (S=P). The figure is from Dinh et al. 41
1.4 Experimental methods 
This section presents the various techniques applied in the present work. Fluorescence 
correlation spectroscopy (FCS) was used in three out of four papers, and is therefore 
more thoroughly described. 
1.4.1 Confocal laser scanning microscopy and fluorescence correlation spectroscopy 
Confocal laser scanning microscopy (CLSM) and fluorescence correlation spectroscopy 
(FCS) were performed on an LSM510/Confocor2 (Carl Zeiss Jena GmbH, Germany). 
The combination of the LSM510 microscope with Confocor2 allows performing FCS at 
well defined spots which are predefined in CLSM images. CLSM was used for imaging 
of xenografts growing in dorsal window chambers in mice (Paper IV) and for imaging 
spheroids (Paper I) and cells (Paper III) before FCS measurements. FCS was used for 
measuring diffusion and interactions of macromolecules in solution (Paper I and II) as 
well as extra- (Paper I), and intracellularly (Paper III). Fluorescence cross-correlation 
spectroscopy (FCCS) was applied to identify bound DNA-chitosan complexes (Paper 
II).
8CLSM is a high-resolution technique and allows 3D reconstruction of thick specimens 
by optical sectioning. A beam of laser light is directed toward the specimen by a beam 
splitter and focused onto a small point at the focal plane of the specimen. A computer 
controlled scanning mirror scans the beam across the specimen in the x-y-direction. 
Out-of-focus fluorescence emission is blocked from reaching the photomultiplier by 
placing a pinhole aperture in the conjugate focal plane to the specimen.  
In FCS mode the scanning mirror is not in use and the measurement is performed at a 
single point with a volume defined by the confocal optics (<1 fl). Due to the small 
detection volume, it is possible to detect even single molecules. FCS was first 
introduced by Madge, Elson and Webb in 1972.49 These early measurements suffered 
from poor signal-to-noise ratios, mainly because of low detection efficiency, large 
concentrations, and insufficient background suppression. A major improvement was 
made by Rigler and coworkers by combining the FCS technique with confocal 
detection.50 To date, most FCS measurements are performed on fluorescently labeled 
biomolecules diffusing in aqueous buffer solution, but the technique is increasingly 
used in tissue and intracellular studies.51-56 In FCS the parameter of interest is not the 
emission intensity itself, but spontaneous intensity fluctuations caused by minute 
deviations from thermal equilibrium. A variety of physical parameters that give rise to 
fluctuations in the fluorescence signal are accessible by FCS, and the method can be 
used to determine concentrations, mobility, and characteristic rate constants of 
molecular reactions. The requirements imposed on a fluorophore in FCS are high 
photostability, high quantum efficiency, and a large absorption cross section.  
Analysis in FCS consists of three basic steps. First, the intensity fluctuations from 
fluorescent particles diffusing through the detection volume are recorded. Subsequently, 
the intensity fluctuations are correlated over time, and the third step is to apply a 
mathematical fitting model that provides access to the desired parameters describing the 
system. Autocorrelation analysis is sufficient for studying mobility, as well as 
interactions if the binding parameters can be linked to a measurable change in mobility. 
Otherwise fluorescent dual-labeling and FCCS are required. In intracellular studies the 
measured molecular mobility will depend on the environment. FCCS may then be a 
valuable tool to verify that slow diffusion stems from dual-labeled complexes and not 
background fluorescence or molecular binding to cellular components. The basic 
principles of fluorescence auto- and cross-correlation spectroscopy are shown in Fig. 3. 
9Figure 3. The basic principles of FCS and FCCS. a) Schematic drawing of the confocal instrumental 
setup. One laser line is used for exciting single-labeled fluorophores. Two laser lines are used for dual-
color FCCS, for which red- and green-shifted fluorescence light are separated by a second dichroic mirror 
and directed through pinholes to their respective detectors. b) Single-color FCS. Fluorescent molecules 
are excited by a laser beam and fluoresce as they travel through the confocal volume. The fluctuations in 
the fluorescence intensity are recorded and an autocorrelation algorithm is applied to the time trace. The 
resulting autocorrelation curve contains information about the concentration of particles in the detection 
volume (dashed line), the characteristic diffusion time (solid line), and other dynamic processes. c) Dual-
color FCCS. Two molecules are fluorescently labeled, and emission from both fluorophores is recorded in 
separate channels (red and green). When the two molecules are bound, they simultaneously fluoresce as 
they diffuse through the detection volume, and colocalized intensity peaks can be observed in the time 
traces for the red and the green channel. The signal in each channel is autocorrelated (solid red and 
green), and the cross-correlation is computed (dashed black). The relative amplitude of the cross-
correlation curve contains information about the degree of binding. The figure is from Schwille et al.52
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A multi-component free diffusion model including triplet decay may be described by 
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where N  is the mean number of particles in the detection volume, T and TU  are the 
triplet fraction and triplet lifetime, respectively, assumed equal for all components, i'  is 
the fractional intensity of the ith species, m the total number of species in the sample, 
and
iD
U  the characteristic translational diffusion time of the ith species through the 
detection volume. xyX  and zX  are the axial and the radial waists of the Gaussian 
detection volume, respectively, defined as the distances at which the intensity drops to 
1/e2 of the maximum intensity.57 For m = 1 and m = 2, Eq. (10) is reduced to the one- 
and two-component diffusion model used in the present work. 
The diffusion coefficient D is related to the characteristic diffusion time and the radial 
waist by 
2
4
= xy
D
D
X
U
 (11) 
For FCS measurements in aqueous solution the free diffusion model is generally 
adequate. In more complex model systems, however, diffusion may be retarded or 
facilitated by flow, and the free diffusion model will fail to describe the system. In such 
cases, an anomalous diffusion model may be more sufficient 
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 (12) 
where B  is the anomaly coefficient.57 The value of B  indicates the degree of anomaly, 
and equals 1 for free, Brownian diffusion. Obstructed diffusion (anomalous 
subdiffusion) is indicated by B  < 1, and B  > 1 represents facilitated diffusion 
(anomalous superdiffusion). 
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When labeling two species (here denoted “red” and “blue”) and studying interactions by 
FCCS, the mobility and concentration of each of the species can still be analyzed by its 
respective autocorrelation function. The cross-correlation amplitude, however, gives 
information about the number of dual-labeled species, i.e. the bound molecules, and can 
be described as 
( ) ( )( )
10 1 1 1br br
cc acr acb r br b br
N NG
N N N N N N N
= + = + = +
+ +
 (13) 
where rN , bN , acrN , acbN , and brN is the number of free red, free blue, total red, total 
blue, and bound red-blue species, respectively.57
1.4.2 Dynamic contrast enhanced MRI
After imaging by CLSM, dynamic contrast enhanced magnetic resonance imaging 
(DCE-MRI) was performed and permeability was estimated in xenografts growing in 
dorsal window chambers (Paper IV). Gadomer was used as a contrast agent. 
DCE-MRI was performed at 7.05 T using a Bruker Biospec Avance 70/20 (Bruker 
Biospin, Ettlingen, Germany). DCE-MRI is a non-invasive technique widely used both 
in the clinic and in research. It has frequently been applied to quantify tumor 
microvascular characteristics like angiogenesis, perfusion, and permeability,20,58-60 and a 
variety of contrast agents are available.61-63 The insufficiency of traditional small 
molecular contrast agents to utilize the hyperpermeability of tumor vasculature has 
encouraged the development of macromolecular contrast agents.63 The spatial resolution 
in DCE-MRI is lower than in CLSM.  
1.4.3 Atomic force microscopy 
The morphology of DNA-chitosan polyplexes (Paper II) was analysed by applying 
tapping mode atomic force microscopy (AFM) on a NanoScope IIIa (Digital 
Instruments, CA) equipped with an E-scanner. In tapping mode AFM a cantilever is 
driven to oscillate near its resonance frequency by a piezoelectric element. Deflections 
of the cantilever caused by interactions with the sample surface are detected as the 
cantilever scans over the dried sample, and a topographic image of the sample is 
produced.64,65 AFM can detect heights of structures with sub-nanometer resolution. The 
12
technique has frequently been used for analyzing polyplexes and has demonstrated that 
condensation of DNA with chitosan forms polyplexes with various shapes, such as rods, 
toroids and globules. 66-68
1.4.4 Other applied techniques 
Dynamic light scattering (DLS) was used to measure the hydrodynamic diameter of 
DNA-chitosan polyplexes (Paper II and III) by using the Zetasizer Nano Zs (Malvern 
Instruments, UK) with a 633 nm laser. DLS is typically used to measure the size of 
particles dissolved in a liquid by illuminating the solution with the laser and detecting 
scattered light at a given scattering angle. The intensity of the fluctuations is dependent 
on the size of the particles and the hydrodynamic diameter of the particles is calculated 
by the Stokes-Einstein relation (Eq. 3). DLS has frequently been used to measure the 
size of polyplexes.40,69
Gel electrophoresis was performed to analyze the stability of DNA-chitosan polyplexes 
(Paper II and III). In gel electrophoresis an electric field forces the polyplex fragments 
to migrate through a gel. DNA molecules normally migrate from negative to positive 
potential due to the net negative charge of the phosphate backbone of the DNA chain, 
and longer molecules migrate more slowly through the gel. Upon condensation by 
polycations, the negative charge is masked. By applying chitosans of various properties, 
the condensation ability of the respective chitosan and stability of the polyplexes are 
analyzed.40,69
Reporter plasmids (gWizTMLuc and gWizTMGFP) containing a cytomegalovirus 
promoter (CMV) and firefly luciferase (Luc) or green fluorescent protein (GFP) was 
complexed with chitosan and introduced into human embryonic kidney (HEK) 293 cells 
by in vitro transfection (see Paper III for details). In vitro investigation of transfection 
efficacy in cell culture is a valuable tool for investigating various promising materials 
for transfection,37 and provides an opportunity to study the transgene expression 
dependence on the chitosan structure on a single cell level.40
Flow cytometry analysis of GFP-expressing cells or polyplex uptake with YOYO-1 
labeled DNA was performed using a BD LSR1 (Becton Dickinson, San Jose, CA) 
(Paper III).  In flow cytometry, laser light of different wavelengths are being directed to 
a stream of fluids where single cells flow through. When cells pass the light beams, 
fluorescence and light scattering are detected and physical and chemical features of the 
13
cells are being analyzed. Flow cytometry of GFP-expressing genes has previously 
shown that chitosan structure affects gene transfer efficacy.40
1.4.5 Data analysis 
A wide range of tools for image analysis and quantitation have been applied and are 
described in the respective papers. 
1.5 Molecular tracers 
1.5.1 Dextrans
Fluorescently labeled dextrans of various molecular weights were used to measure 
interstitial diffusion (Paper I) and vascular permeability (Paper IV), and as an 
intravascular agent to image blood vessels (Paper IV). Dextrans are neutrally charged, 
complex, branched glucans of various lengths, and are commercially available in a wide 
range of molecular weights, also with fluorescent probes attached. They are frequently 
used both as tracers and drug carriers, have no affinity for cells, and are ideal for 
diffusion measurements.70-72
1.5.2 IgG
Extracellular diffusion of antibody immunoglobulin IgG was compared to that of 
dextrans (Paper I). IgG is a monomeric immunoglobulin, has a globular structure, and a 
molecular weight of 150 kDa. It is the most abundant immunoglobulin and is 
approximately equally distributed in blood and in tissue liquids. IgG is also non-specific 
and suited for diffusion measurements.73
1.5.3 DNA-chitosan polyplexes 
Complexation, kinetics, and morphology of fluorescently labeled DNA-chitosan 
polyplexes were studied (Paper II and III). Chitosan, a biopolymer derived from chitin, 
has been shown to efficiently compact DNA and protect it from degradation by 
nucleases,74 and the interest in chitosan as a non-viral vector in gene delivery is 
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increasing.75,76 Although not as efficient as its viral counterparts, chitosan is 
biocompatible, exhibit low immunogenicity and less cytotoxicity than viral vectors.40,77
Chitosan is a linear polysaccharide composed of ( )1 4l -C -linked N-acetyl-D-
glucosamine (acetylated units) and D-glucosamine (de-N-acetylated units) residues. It 
can be structurally and functionally modified to enhance gene transfer efficacy.40,77
1.5.4 Gadomer
The contrast agent Gadomer was used to measure permeability in tumor blood vessels 
by DCE-MRI (Paper IV), and the results were compared to relevant parameters 
obtained with CLSM. Gadomer is a synthetic dendritic gadolinium (Gd) chelate 
carrying 24 Gd. Each of the 24 amino groups of the outmost 12 L-lysine residues are 
covalently linked to a macrocyclic Gd complex, resulting in a high Gd density per 
molecule. Gadomer has a molecular weight about 17 kDa. Because of the globular 
shape of the molecule, the apparent molecular weight is about 30 - 35 kDa.62 Gadomer 
is developed as an intravascular agent, but due to the leakiness of tumor blood vessels it 
extravasates in tumor tissue. The acute systemic tolerance of Gadomer is high and it is 
rapidly and completely eliminated from the body mainly via glomerular filtration.62 The 
T1 relaxivity of Gadomer at 7T have been estimated to 7 mM-1s-1 (personal 
communication, Bayer Schering Pharma AG, Berlin, Germany, March 2009).  
1.6 Model systems 
1.6.1 Hydrogels
A 5% gelatin hydrogel was used to mimic the collagen network of ECM in tissue (0.2 - 
2%)78,79 and diffusion of dextrans and IgG was measured by FCS (Paper I). Gelatin is 
produced by partially hydrolysis of collagen. By heating, the molecular bonds that 
provide stability to the triple helical structure of collagen are broken. When the melted 
gelatin is cooled, the hydrogen bonds reestablish in a random fashion and the gelatin 
strands assemble into a gel network.
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1.6.2 Cell lines 
Intracellular experiments (in vitro transfection, gel electrophoresis, flow cytometry, 
CLSM, and FCS) of DNA-chitosan polyplexes were performed using human embryonic 
kidney 293 cells (HEK293) obtained from ATCC (Rockville, MD, USA) (Paper III).  
The human osteosarcoma cell line (OHS) was established at the Norwegian Radium 
Hospital from a patient with multiple skeletal manifestations of osteosarcoma.80 In the 
present work, OHS cells were used for growing multicellular spheroids (Paper I) and for 
xenografts growing in the intravital window chamber model (Paper IV). 
1.6.3 Multicellular spheroids 
Multicellular spheroids of OHS cells were used to mimic the ECM of tumor tissue, and 
diffusion of dextrans and IgG was measured by FCS (Paper I). A multicellular spheroid 
consists of cells growing in a 3D structure.81 Multicellular spheroids simulate 
micrometastases or intravascular microregions of larger tumors, and show growth 
kinetics similar to those of tumors in vivo. OHS spheroids produce ECM with an 
intermediate composition to that of xenografts and monolayers.82
1.6.4 Dorsal window chambers 
Tumors growing in observation chambers in animals give a unique opportunity for 
intravital studies of tumor pathophysiology.71,72,83 OHS cells were grown in dorsal 
window chambers, and implanted in nude mice as described by Endrich et al.84 to 
provide a vascular tumor model for combined CLSM and MRI (Paper IV). For this 
purpose, window chambers in MRI-compatible material, poloxy methylene (POM), 
were produced (Fig. 4). The plastic chambers resemble traditional titanium chambers
but the size was made smaller to reduce the burden on the animal. A device for fixing 
the chamber to the MRI surface coil was produced to prevent movement artifacts during 
imaging. 
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Figure 4. a) Schematic drawing of dorsal window chamber in MRI-compatible material (POM). The hole 
in the centre is covered by a transparent glass cover slip which is fixed with a clamping ring. The 
chamber has a total weight of 2.0 g. All parts were produced by the in-house workshop, except for the 
glass cover slip (Assistent, Germany) b) The MRI-compatible dorsal window chamber implanted in a 
nude mouse. A circular area is removed from one layer of skin under the glass cover slip, providing a 
window to the tissue.  
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2  Objectives of the study 
New approaches to drug delivery strive to develop target-selective nanomedicine in 
order to minimize systemic side-effects. The overall motivation for the present work 
was to establish robust and accurate tools for determining characteristic properties of 
nanomedicine and tissue, and for understanding the transport mechanisms in the various 
tissue subcompartments. 
The enhanced permeability of tumor vasculature facilitates passive transport across the 
capillary walls, and is a source of selective cancer therapy. It has been shown that the 
permeability may be related to the microvascular structure of the tissue.14,85-88 DCE-
MRI has frequently been used to study vascular permeability of tumor tissue,58,59,89 but 
limited spatial resolution makes the technique unsuitable to detect the extensive 
heterogeneity of tumor tissue. We therefore aimed at complementing DCE-MRI with 
CLSM to detect local variations in permeability and microvascular morphology. The 
dorsal window chamber allowed intravital imaging of the same tissue with both 
methods, and has recently received attention as a potential tumor model for multimodal 
imaging with MRI.90,91
A prerequisite for successful therapy is that the therapeutic agents reach the target cells. 
Because of the elevated IFP in tumors, both transvascular and interstitial transport of 
nanomedicine largely depend on diffusion, which is extremely slow for these large sized 
molecules. It is therefore important to establish methods for studying the nature of 
diffusion and the properties of nanomedicine and tissue that influence this transport 
mechanism. We sought to establish FCS as a method for studying interstitial diffusion.  
The success of the human genome project has made it possible to diagnose errors in 
genes. The next challenge is to develop gene therapy based on this knowledge. The size 
and negative charge of the DNA molecule constitute a barrier to gene delivery and 
effort is made to develop vectors with properties that facilitate transport, uptake, and 
transfection efficacy. Chitosan is a nonviral vector which can be structurally modified in 
order to enhance gene delivery efficacy.40,47,69,77,92 We wished to explore how various 
structural properties of chitosan influenced the DNA condensation and the delivery of 
the DNA-chitosan polyplexes. 
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The specific aims of the present work were to: 
•  design an MRI-compatible dorsal window chamber in order to investigate the 
potential of CLSM and MRI as complementary techniques. 
•  study microvascular structure and transvascular transport in OHS tumor tissue  
with CLSM and MRI using the dorsal window chamber model. 
•  establish FCS as a method for studying extracellular diffusion and correlate  
results with previously measured diffusion by FRAP. 
•  establish protocols for fluorescent dual-labeling of DNA-chitosan polyplexes for  
CLSM and FCS studies. 
•  characterize DNA-chitosan polyplexes formed by structurally different  
chitosans. 
•  study the effect of structural modification of chitosan on intracellular trafficking,  
dissociation, and transfection efficacy of DNA-chitosan polyplexes in cells. 
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3  Summary of results 
Paper I 
FCS was used to study extracellular diffusion of IgG and tetramethylrhodamine(TMR)-
labeled dextrans (155 kDa and 2 MDa). A 5% hydrogel and OHS spheroids were used 
to mimic the extracellular matrix in tissue. The novel aspect of this work was to apply 
FCS for extracellular diffusion measurements in spheroids. The diffusion coefficients 
were shown to depend on the complexity of the environment, as well as on the size and 
structural shape of the diffusing molecules. The results were validated by comparison to 
diffusion coefficients previously obtained with two-photon fluorescence recovery after 
photobleaching (FRAP) using the same microscope (Zeiss LSM510 META/Confocor2).
However, FCS provided additional information to FRAP by revealing anomalous 
subdiffusion or two-component diffusion.
Paper II 
For the purpose of investigating the structure-function relationship of chitosan as a gene 
vector, we characterized condensation of DNA in solution by three molecularly tailored 
chitosans, including linear (LCO), trisaccharide substituted- (TCO), and self-branched 
trisaccharide substituted (SB-TCO) chitosan oligomers. We used FCS, AFM, and DLS 
to characterize size, structure, and mobility of the polyplexes, as well as interactions 
between DNA and chitosan. All three chitosans formed complexes with shapes of 
globules and rods, and almost no toroids were seen. The asphericity distribution showed 
that SB-TCO formed a higher fraction (0.84) of globules than LCO (0.58) and TCO 
(0.61). AFM topographs also revealed that the average heights of SB-TCO were larger 
than for LCO and TCO for both globules and rods. Using an A/P ratio of 10, we 
observed a lower fraction of bound chitosan (30%) after complexation of DNA with 
SB-TCO than with LCO and TCO. We sought to establish a protocol for fluorescently 
dual-labeling of the polyplexes. FCCS was performed and demonstrated that DNA and 
chitosan were bound together. Several fluorescent DNA-labels were tested, and YOYO-
1 had less effect on the size and structure of the complexes than Cy5 and PicoGreen.  
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Paper III 
The structure-function relationship of chitosan gene delivery was studied intracellularly 
in HEK293 cells. By varying the A/P ratio and the substitution (LCO and TCO) and 
chain length (DPn 21 – 88) of the chitosans, we studied the relationship between these 
parameters and formulation properties, cellular uptake of polyplexes, and gene transfer 
efficacy. At a given A/P ratio the various chitosans formed complexes with similar 
uptake but highly variable transfection efficacy. The maximum gene expression was 
achieved with DPn 31-42 and an increase in chain length and A/P ratios reduced and 
delayed luciferase expression. The gene transfer pattern correlated with the heparin 
induced unpacking of polyplexes. Substituting the chitosan by uncharged 
oligosaccharides weakened the interaction with DNA and reduced or enhanced 
transfection efficacy, depending on the chain length and A/P ratio. The magnitude of 
gene expression was also controlled by the size of the substituent. CLSM and FCS 
demonstrated that the polyplexes were internalized as aggregates and that they were 
transported to the nucleus. Furthermore, FCS revealed that free chitosan was diffusing 
in the cytoplasm and the nucleus.  
Paper IV 
For the purpose of combining CLSM and MRI for studying microvascular architecture 
and function of tumor tissue, we designed a dorsal window chamber in MRI-compatible 
material (POM). We then applied CLSM and DCE-MRI to study microvascular 
structure and permeability of OHS tumors growing in dorsal window chambers 
implanted in mice. The volume transfer coefficient and the time-to-peak extracted from 
the DCE-MRI concentration-time curves of Gadomer were shown to correlate with the 
extravasation rate and initial slope of the fluorescence intensity-time curves of 40 kDa 
dextran, respectively. However, CLSM was able to discriminate between tumors and 
normal tissue, whereas DCE-MRI was not. Furthermore, the extravasation rate 
correlated with vascular density, number of branching points, and fractal dimension, 
which were all significantly higher in tumors than in normal tissue. A high degree of 
heterogeneity within a tumor was observed. 
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4  General discussion 
A number of techniques were applied to study the delivery of nanomedicine to tissue. 
We investigated molecular structures and interactions (Paper II, III), and measured 
transvascular (Paper IV), extracellular (Paper I), and intracellular (Paper III) transport of 
macromolecules. In such complex environments a wide range of error sources may 
interfere with the results. We therefore compared several techniques for validation of 
the results. In light of our results, the following sections will briefly describe vascular, 
interstitial, and intracellular aspects of drug delivery. The potentials of the main applied 
techniques (CLSM, MRI, and FCS) will also be discussed. 
4.1 Transport of nanomedicine from vasculature to intracellular targets 
4.1.1 Transvascular transport and microvascular architecture 
Abnormal vasculature and enhanced permeability are characteristics of tumors and may 
predict therapeutic response.93-97 To study these phenomena in OHS tumors, 
extravasation of Gadomer and 40 kDa dextran was successfully measured by CLSM 
and DCE-MRI, respectively (Paper IV). The two techniques yielded correlating results. 
Vascular permeability has previously been shown to vary with tumor model, stage, and 
properties of the molecular tracer.18-20,58,59,61 In the present work, both CLSM and DCE-
MRI indicated lower extravasation of the respective tracers compared to previously 
measured results.59,98 Although we used different model systems (tumor model, 
molecular tracer, and animal), our results may indicate that the permeability of OHS 
tumor vessels is not very enhanced, even if a difference in extravasation and 
microvascular structure compared to normal tissue was found in the present work 
(Paper IV). 
Fractal dimension is a structural parameter that gives information about vascular 
architecture, tumor growth and angiogenesis.31 In the present study, fractal dimension 
was shown to correlate positively with extravasation and structural parameters like 
vascular density, vascular volume fraction, and the number of branching points (Paper 
IV). However, whereas structural parameters, e.g. the vascular density, vary for 
different tumor types, the fractal dimension is shown to be a robust, reproducible, and 
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reliable parameter.23,30 The strong correlation between extravasation and structural 
parameters demonstrated in this work supports that microvascular structure can predict 
transvascular transport of macromolecules. Few previous studies have directly related 
permeability to microvasculature structure using dorsal window chambers.90
Both transvascular and interstitial transport is largely obstructed by the elevated IFP in 
tumors. The abnormal vasculature in tumors may contribute to malignant properties and 
prevent successful delivery of therapeutic anti-cancer agents. It has been demonstrated 
that normalization of the vasculature by applying anti-angiogenetic therapies leads to 
less leaky and less tortuous vessels, lower IFP, and improved penetration of drugs.86-
88,99-101 This implies that also interstitial transport may be determined by the 
microvascular architecture. 
4.1.2 Interstitial transport; diffusion 
The high IFP in the central parts of a tumor induces an outward pressure gradient, and 
macromolecular therapeutic agents at the periphery of the tumor have to diffuse through 
the interstitial space against this gradient to penetrate into the tumor.9,14 The study of 
mechanisms that determine interstitial diffusion is therefore of high importance to 
improve the diagnosis and treatment of tumors.  
The constituents of the ECM, including collagen, glycosaminoglycans, and 
proteoglycans, form a complex structured gel that obstructs mobility of 
macromolecules.73 This was demonstrated by retarded diffusion of IgG and 155 kDa 
and 2 MDa dextrans in 5% hydrogel and extracellularly in OHS spheroids compared to 
solution (Paper I). The concentration of collagen in the ECM may be an important 
determinant of diffusion.72,78,102,103 The 5% gelatin hydrogel has comparable collagen 
density to that of ECM in tissue (0.2 - 2%),78,79 and was therefore considered a relevant 
model for tumor ECM. The collagen content in OHS spheroids is lower (0.05%, 
unpublished data). At a given depth into the spheroids, the effect of the ECM network 
on diffusion depended on the molecular weight of the tracer (Paper I). The two smaller 
molecules diffused more slowly in the gel than in spheroids. However, the ECM of 
spheroids seemed to be a significant barrier for a larger molecules (Paper I), as 
suggested by a slower diffusion of 2MDa dextran in spheroids than in gel. However, 
interstitial diffusion depends not only on the weight, but also on structure of the 
diffusing molecule (Paper I). When one-component (free or anomalous) diffusion was 
estimated, diffusion of the globular IgG was faster than that of the similar-sized linear 
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dextran in solution, gel, and spheroids. Berk et al.104 previously demonstrated the same 
tendency in solution, but contradictory results have also been reported.70
In complex, heterogeneous environments, the mobility of molecules may not be 
sufficiently described by free diffusion. Anomalous diffusion in the interstitium due to 
various underlying processes has been suggested (e.g. molecular binding, adsorption to 
chains of the structural meshwork, and molecular crowding).34,105,106 Another hypothesis 
is that the interstitial space consists of two phases; a viscous gel compartment 
containing mainly collagen, elastin, and polysaccharides, and a free-fluid space.13,107
Diffusion in the free-fluid space has been shown to be close to that in water both in 
tumors and normal tissue. The higher effective diffusion coefficients that have been 
measured in tumors compared to normal tissue108,109 have therefore been attributed to 
less resistance to macromolecular transport in the gel space of the tumors. This 
hypothesis has been supported by lower amounts of glycosaminoglycans found in 
several tumors.110 However, enhanced diffusion in tumors may also be explained by a 
larger interstitial space than in normal tissue, which may cause less resistance to 
diffusion.13 We demonstrated that diffusion in gel and spheroids could be equally well 
described by an anomalous and a two-compartment model (Paper I). Studying whether 
the diffusion mechanism in the interstitium is better described by free, anomalous, or 
two-compartment diffusion may give valuable information about the structural 
properties of the ECM.  
4.1.3 Intracellular transport 
The final target of the therapeutic agents is the cell itself or an intracellular structure. 
Insight into endocytic pathways and intracellular trafficking is a prerequisite for 
successful drug delivery. In the present work intracellular transport was investigated by 
studying chitosan-mediated gene delivery (Paper III).
Chitosan is a nonviral vector that can be structurally modified. Several studies of DNA-
chitosan polyplexes have been performed in order to gain basic insight into the 
complexation mechanisms and the effect of structural modification, both in solution 
(paper II) and in cells (paper III).40,47,66,67,69 We complexed DNA with chitosan of 
different chain lengths and degrees of substitution, including unsubstituted (LCO), 
trisaccharide substituted (TCO), and self-branched trisaccharide substituted chitosan 
oligomers (SB-TCO), and demonstrated that these parameters, as well as A/P ratio, 
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influenced the size, structure, mobility and transfer efficacy of DNA-chitosan 
polyplexes (Paper II and III).  
DNA-chitosan polyplexes have been shown to take various forms; rods, toroids, and 
globules.66,67 At A/P 10, DNA condensed by SB-TCO in solution formed larger 
complexes with a higher fraction of globules to rods than LCO and TCO (Paper II). The 
length of the DNA used in the present study was 6.7 kb. It has been reported that the 
length of the DNA is a determinant of the resulting polyplex structure. Whereas a 
minimum length of about 400 bp has been reported for the formation of toroids,39,111 it 
has been suggested that above a certain length, DNA will condense into globules rather 
than rods. The larger structures of complexes formed by SB-TCO, which was the longer 
chitosan, may be due to more efficient binding. For longer chitosans, fewer molecules 
may be necessary to condense DNA, which can explain why SB-TCO formed a higher 
fraction of free chitosan after complexation compared to LCO and TCO. This is 
interesting because a high fraction of free polycations may improve the transgene 
delivery47,112 due to enhanced buffering capacity leading to endosomal escape of the 
complexes, and may explain why SB-TCO yields higher transfection efficacy compared 
to LCO and TCO.40
It has previously been demonstrated that low molecular weight chitosan oligomers (DPn
18-25) mediate more efficient gene transfer than heavier chitosans (210 kDa).47 In the 
present study, we identified a narrow interval of chain lengths between DPn 30-40 that 
mediated superior transgene expression irrespective to the A/P (Paper III). This 
enhanced transfection efficacy may be due to more efficient cellular processing of the 
delivered DNA rather than more efficient delivery of DNA into the cells. Intracellular 
diffusion of polyplexes demonstrated two diffusing components (Paper III). The fast 
diffusing component was comparable to that in solution (Paper II) and in cells 
transfected by free chitosan (Paper III). The fast component was therefore identified as 
free chitosan. The slow diffusion component in cells (Paper III) was in the lower range 
of what was found for the respective complexes in solution (Paper II). The slow 
diffusion may thus origin from complexes diffusing in a more viscous media than 
solution. It may also arise from complexes, or even free chitosan, that have aggregated 
or bound to mobile cellular components. Aggregation could also be observed in 
confocal images (Paper III) but the images revealed no differences between DPn 31 and 
88 in polyplex unpacking and intracellular trafficking that could explain a difference in 
transfection efficacy. We showed that polyplex formed by linear chitosan at A/P 10 
contained about 50% of free unbound chitosan (Paper II) and it seemed like this free 
chitosan also entered the cells together with the polyplexes (Paper III). The presence of 
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chitosan in the cytosol and nucleus indicates that chitosans and polyplexes are able to 
escape lysosomal degradation and are transported to the nucleus.
In this work we showed that substitution of chitosan determined the polyplex structure 
and mobility (Paper II) which may be related to intracellular trafficking. We further 
demonstrated that A/P ratio as well as chitosan chain length and substitution influenced 
the intracellular uptake and transfection efficacy (Paper III). 
4.2 The potential of CLSM and MRI as complementary techniques 
Microvasculature and vascular permeability of solid tumors may determine therapeutic 
response and it is of clinical relevance to develop robust methods that quantify these 
parameters. MRI is frequently used for determining permeability and structural features 
of tumors.20,59,90,113-115 However, because tumors are functionally and structurally highly 
heterogeneous, there are local variations within a tumor that may not be detectable by 
MRI due to the limited spatial resolution of the technique. By complementing MRI with 
CLSM we sought to investigate these local variations on a microscopic level and to 
validate results obtained with MRI. 
By using 40 kDa dextran and Gadomer as macromolecular tracers for CLSM and DCE-
MRI, respectively, permeability and microvascular structure of OHS tumors growing in 
dorsal window chambers in mice were studied (Paper IV). For relevant comparison, the 
two techniques were applied on the same animal. Correlation in permeability was found 
for the two methods. However, a difference in permeability between normal and tumor 
tissue was detectable by CLSM, but not by DCE-MRI. This may be due to the 
differences in the CLSM and MRI experimental setups, which are discussed below. 
4.2.1 ROIs and measuring depth in the tissue 
A limiting factor of CLSM is the short penetration depth in tissue. Whereas the 
maximum penetration depth for CLSM was 50 - 140 mμ  dependent on the tissue, the 
whole tumor depth was accessible with MRI. Also, whereas the optical section in 
CLSM was 4.5 mμ , DCE-MRI required a larger slice thickness (0.3 mm) for sufficient 
signal-to-noise ratio. Thus, the measuring depth and the slice thickness of the analyzed 
tissue were different for the two techniques. 
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Whereas the CLSM analysis of permeability was performed based on vascular mask of 
the images (FOV 2460 68 460 68 m. . μ× ), the DCE-MRI ROIs were defined as the 3D 
volume demonstrating signal enhancement in the chamber. It was our intension to 
perform pixel-based DCE-MRI analysis.116 Using this technique the heterogeneity of 
the tissue detected by DCE-MRI would be taken into account, and coregistration with 
CLSM could provide information about processes within a single MRI voxel. Due to 
the thin tissue slice confined in the chamber ( 0.5 mm for tumors, < 0.5 mm for 
normal tissue), the SNR was too low to allow pixel-based DCE-MRI.  
4.2.2 Molecular tracers 
The reason why CLSM detected differences between tumors and normal tissue, whereas 
DCE-MRI did not, may be the use of different molecular tracers. In a previous study 
using Gadomer as a contrast agent, a higher permeability was demonstrated in infarcted 
myocardium compared to normal myocardium, whereas no difference was found 
between tumor and normal tissue.58 Ideally, CLSM and DCE-MRI should be performed 
simultaneously and with the use of the same molecular tracer. In the present work, the 
multimodal contrast agent AlbuminGd-DTPA ( 90 kDa) was synthesized according to 
the procedure described by Ogan,117 fluorescently labeled and applied (data not shown), 
but extravasation in OHS tumors was not detected by CLSM or MRI. High-performance 
liquid chromatography (HPLC) analysis of AlbumGd-DTPA revealed a polydispersity 
with molecular weights up to 600 kDa, and molecules of this size were not expected to 
extravasate. We therefore chose the smaller and highly soluble contrast agent Gadomer, 
which is considered an intravascular contrast agent which extravasates only in diseased 
tissue.61 Gadomer17, a precursor of Gadomer, has previously been fluorescently labeled 
with fluorescein isothiocyanate (FITC).118 However, all amines on Gadomer are 
occupied by Gd and it can not be fluorescently labeled.62 We therefore chose a similar-
sized, well characterized, fluorescently labeled dextran (40 kDa) for CLSM. 
4.2.3 Mathematical models applied for extracting permeability parameters  
The Patlak119 and Tofts114 models were the main mathematical models successfully 
applied to the CLSM and DCE-MRI data, respectively. The more simplified Patlak 
model requires fewer input parameters and has previously been used to estimate 
apparent permeability of 40 kDa dextran in P22 sarcomas in rats using the dorsal 
window chamber model.98 Whereas the Patlak model assumes irreversible leakage, the 
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Tofts model take into account the efflux from the tissue compartment into the blood, 
which may be a more realistic model. The fact that the two models describe somewhat 
different processes could be a source of error. However, the validity of the Patlak model 
for tumor tissue was evident by the increasing, linear terminal slope. 
4.2.4 The dorsal window chamber 
The vascular system of human tumor xenografts growing in dorsal window chambers in 
nude mice provides an opportunity to extract experimental parameters unavailable in 
avascular tumor models. A drawback of this model is that the tissue pressure may be 
elevated and lead to pressure necrosis.120 Another concern regarding this model is that 
the risk of infections, which is relatively high, could give artifacts because enhanced 
vascular permeability is also observed in inflammatory and infected tissue.121 Tumor 
tissue may still be identified because macromolecules are cleared more rapidly from 
normal inflammatory tissue compared to tumor tissue. In this work, an MRI-compatible 
dorsal window chamber was produced. The size of the chamber was reduced and the 
material (POM) lighter compared to its titanium counterpart, significantly reducing the 
stress on the animals and thereby the risk of infections. Although few studies have been 
published, there is an interest in utilizing dorsal window chambers to cross-validate 
results from MRI and optical imaging.90,91,122
Despite the different basic principles and the different experimental setups of CLSM 
and MRI, our work shows that the MRI-compatible dorsal window chamber allows 
combining CLSM and MRI to yield complementary and supportive information about 
macromolecular permeability in tumors. It has also shown to be a valuable model in 
revealing the relation between permeability and microvascular structure represented by 
vascular density, vascular volume, and fractal dimension. 
4.3 FCS as a tool for characterizing mobility and molecular interactions in tissue 
One-photon FCS was successfully applied as a method for measuring interstitial 
diffusion in tissue (Paper I). The novel aspect of this work was the use of FCS to 
measure extracellular diffusion in multicellular spheroids. The diffusion coefficients 
obtained by FCS were validated with diffusion coefficients measured by two-photon 
FRAP on the same microscope, showing that these two techniques can support each 
other. However, FCS is a more sensitive method than FRAP and can detect translational 
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and rotational diffusion, interactions, concentrations, conformation changes, and triplet 
state kinetics.56,123-125 Due to the high sensitivity, FCS can also reveal anomalous sub-
diffusion or multiphase diffusion (Paper I) and thus provide additional information to 
FRAP.
FCS was further used for measuring kinetics and interactions of DNA-chitosan 
polyplexes (Paper II and III). Effort was made to choose suitable fluorophores (Paper II) 
for dual-labeling of the polyplexes in order to perform cross-correlation (FCCS) in 
future cell experiments. In intracellular experiments, FCCS is a valuable tool for 
verifying that DNA and chitosan are bound together,125,126 whereas autocorrelation 
analysis may mistake aggregates or binding to cellular compartments for being 
complexes. Alexa Fluor 647 and YOYO-1 (both from Molecular Probes, Eugene, OR) 
was chosen as labels for chitosan and DNA, respectively. YOYO-1 has previously been 
used as a fluorescent DNA-label in confocal imaging.127-129 A problem with FCCS of 
the dual-labeled DNA-chitosan complexes was the large extent of free chitosan, which 
contributed to a very high count rate for the Alexa Fluor 647 fluorescence. We therefore 
had to minimize the concentration, which resulted in a very low DNA concentration and 
a low YOYO-1 count rate. This was not a problem in solution (Paper II), but in cells the 
YOYO-1 signal was suppressed by the background autofluorescence. Removal of free 
chitosan was not considered an alternative because it may be disadvantageous for gene 
transfer efficacy, and we therefore focused on autocorrelation analysis of intracellular 
mobility and localization of single-labeled DNA-chitosan with Alexa Fluor 647 (Paper 
III). The ability of FCS to simultaneously detect two diffusing components made it 
possible to determine the fraction of free chitosan and chitosan bound to complexes 
(Paper II and III), which provides valuable information about interactions between DNA 
and chitosan.
Both extra- and intracellular FCS measurements were difficult due to complex and 
heterogeneous environments. The high sensitivity of the technique makes it vulnerable 
to scattering, autofluorescence, and photobleaching in cellular environments, and the 
maximum depth for performing one-photon FCS in tissue is limited. FCS measurements 
were performed 30 mμ  into spheroids (Paper I), and the signal quickly diminished with 
increasing depth. However, by using two-photon FCS and the dorsal window chamber 
model, Alexandrakis showed that the maximum measuring depth for FCS in solid 
tumors was 140 mμ  for 2 MDa dextran and 120 mμ  for IgG.54 In intracellular FCS 
experiments, a complicating factor is that the DNA-chitosan complexes tend to 
aggregate at physiological pH (Paper II).40 Aggregation or binding of complexes to the 
cell membrane may cause FCS to fail as a method, either due to high concentrations 
29
inducing low SNR, too slow diffusion for the accessible time window of the 
LSM/Confocor2 software, or immobile complexes. In such cases, the autocorrelation 
function may be distorted or artifacts may yield erroneous quantitative values. FCS 
should therefore be supported by other methods when performed in complex 
environments. In Paper I, this was accomplished by comparing FCS and FRAP. In 
Paper III, the problem was circumvented by qualitatively comparing FCS results for the 
various chitosans. In Paper II, FCS was qualitatively validated by AFM and DLS. The 
results obtained in complex environments, like spheroids and cells, were thus supported 
by other techniques and by pre-characterization of mobility in solution. FCS is, 
however, a valuable tool for measuring diffusion and detecting molecules where 
concentrations are too low for detection by other techniques, e.g. CLSM. Therefore, 
studies of DNA-chitosan with FCCS and CLSM can be performed simultaneously in the 
same cell and give complementary information about co-localization, kinetics, and 
interactions. Further effort will be made to establish protocols for intracellular FCCS. 
This work has shown that FCS is a versatile method in drug delivery research. Although 
FCS is a challenging technique in complex environments, we have demonstrated its 
potential in characterizing molecular structure, mobility, and interactions in solution 
(Paper I and II), as well as extracellularly in spheroids (Paper I) and in cells (Paper III).  
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5  Conclusion and future perspectives 
Novel and well established methods were used to study structural and functional 
parameters of tissue. The versatility of fluorescent techniques in studying drug delivery 
was demonstrated. The confocal microscope was used to validate or support results 
obtained with a number of other techniques in characterizing extracellular, intracellular 
and transvascular transport and uptake of nanomedicine. 
Permeability in tumor tissue measured by DCE-MRI correlated with results obtained by 
CLSM, and a relation between microvascular morphology and permeability was 
observed. This demonstrated that the dorsal window chamber model allowed us to 
obtain complementary information about structure and function of tumor vasculature by 
using CLSM and MRI. We designed an MRI-compatible dorsal window chamber which 
proved to be well functioning for both techniques. The chamber is now ready to be used 
in combined CLSM and MRI for studying a variety of parameters. The experimental 
setup may be improved by further optimizing the MRI protocols, and designing a 
dedicated surface coil may increase the SNR. There is an increasing interest in 
multimodal imaging and a number of multimodal MRI contrast agents for various 
applications exist.130 For future experiments, effort will be made in finding multimodal 
tracers with suitable properties that can be used both as MRI contrast agents and as 
fluorescent tracers in CLSM. 
The sensitivity of FCS to background noise and autofluorescence constituted a 
challenge when performing experiments in living tissue. However, FCS proved to be a 
suitable technique for diffusion measurements both intra- and extracellularly. FCS was 
successfully used to measure diffusion extracellularly in spheroids and the results 
corresponded well with previously obtained FRAP measurements on the same 
microscope and with the same molecular tracers. Extracellular diffusion was shown to 
depend on molecular weight, structure, and the complexity of the model system. FCS 
provided additional information to FRAP by revealing a two-phase or an anomalous 
nature of the transport in gel and spheroids. Hence, to further explore the nature of 
diffusion in the interstitium may give valuable information about the structural 
properties of the ECM. 
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FCS provided new information about the functional and morphological variations of 
structurally modified gene vectors. By studying the structure-function relationship of 
chitosan, we sought to determine the relationship between structure and transfection 
efficacy. In combination with other techniques, FCS revealed that the A/P ratio, chain 
length, and the degree of substitution of chitosan affected the size, structure, mobility, 
extent of free chitosan after complexation, aggregation, and transfer efficacy of DNA-
chitosan polyplexes. The results are interesting with respect to transfection in several 
manners. A high fraction of free chitosan may be advantageous for endosomal release,40
and could be a determinant of transfection efficacy. Free chitosan was detected by FCS 
in the cytoplasma and the nucleus, which indicates that the polyplexes are able to escape 
lysosomal degradation and be transported to the nucleus. In conclusion, the results gave 
no clear evidences on how the transfection efficacy is determined by the chitosan 
structure. The studies on condensation, uptake, and intracellular trafficking of DNA 
complexed with structurally modified chitosans in cells will therefore be continued. For 
future experiments, we will further optimize the protocol for fluorescent dual-labeling in 
order to perform intracellular FCCS. The high count rate from unbound fluorescently 
labeled chitosans diminished the fluorescence signal from labeled DNA, and this is a 
challenge that must be overcome. We will therefore seek to find fluorophores with more 
sufficient properties for our purpose. Removal of the free chitosan may not be favorable 
to transfection, but if the fluorescence of the chitosan label is sufficiently high, the 
detected count rate may be reduced by labeling only a fraction of the chitosans in the 
sample.  
The present work has demonstrated the potential of FCS, CLSM, MRI, and other 
techniques applied in the study as valuable tools in drug delivery research. By further 
improving the experimental setups, these techniques may provide new and 
complementary insight into the structure and function of the vascular, extracellular, and 
intracellular tissue compartments. 
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Abstract. Diffusion of therapeutic macromolecules through the extra-
cellular matrix of tumor tissue is a crucial step in drug delivery. We
use ﬂuorescence correlation spectroscopy FCS to measure diffusion
of IgG 150 kDa and dextrans 155 kDa and 2 MDa in solution,
5% gelatin hydrogel, and multicellular spheroids. Gel and spheroids
are used as model systems for the extracellular matrix. The diffusion
depends on the complexity of the environment, as well as on the size
and structural shape of the diffusing molecules. The results based on
one-photon FCS are in good agreement with diffusion coefﬁcients ob-
tained with two-photon ﬂuorescence recovery after photobleaching
FRAP using the same microscope Zeiss LSM510 META/Confocor2.
However, FCS reveals anomalous or multicomponent diffusion in gel
and spheroids, which are not resolvable with FRAP. This study dem-
onstrates that one-photon FCS can be used to study the extracellular
transport of macromolecules in tumor tissue, and that FCS provides
additional information about diffusion properties compared to FRAP.
© 2008 Society of Photo-Optical Instrumentation Engineers. DOI: 10.1117/1.2982530
Keywords: ﬂuorescence spectroscopy; correlation; tissues; confocal optics;
diffusion; biology.
Paper 08046R received Feb. 5, 2008; revised manuscript received Jun. 9, 2008;
accepted for publication Jun. 15, 2008; published online Oct. 14, 2008.
1 Introduction
The study of molecular dynamics in tissue provides valuable
information about processes in the living organism. Insight
into molecular binding, interactions, transport, and distribu-
tion, as well as the development of noninvasive techniques
that provide such information, are crucial. In cancer research,
it is important to acquire knowledge about delivery and phar-
macokinetics of macromolecular anticancer agents e.g., anti-
bodies, liposomes, and DNA vectors, which are of great in-
terest in therapy due to their speciﬁcity for tumor tissue.
However, these large molecules have to overcome severe
physiological barriers on their way from the blood vessels,
through the extracellular matrix ECM and into the cancer
cells, and only a minor fraction of the injected therapeutic
macromolecules accumulates in tumor tissue.1,2 Due to the
high interstitial ﬂuid pressure in tumors,1,3 diffusion is the
major interstitial transport mechanism. The ECM consists of a
protein network embedded in a hydrophilic gel of glycosami-
noglycans and proteoglycans, and this complex structure
slows down diffusion of the therapeutic agents.4 It is therefore
of clinical importance to study diffusion and factors that in-
ﬂuence transport behavior in the ECM.
Fluorescence correlation spectroscopy FCS5,6 is a tech-
nique for measuring molecular dynamics and interactions, and
the number of studies in living cells and tissue is
increasing.7–11 The principle of FCS is to detect intensity ﬂuc-
tuations from ﬂuorescent molecules in a small detection vol-
ume deﬁned by a focused laser beam. The temporal correla-
tion of the intensity ﬂuctuations yields valuable information
about molecular properties like translational and rotational
diffusion, interactions, concentration, and conformation
changes. A low concentration of ﬂuorescent molecules is es-
sential to obtain proper correlation amplitudes, and this is an
advantage when studying biological tissue.
FCS is a highly sensitive technique and not straightforward
in complex systems like cellular environments. Heterogeneity,
scattering, tissue absorption, low detection efﬁciency, photo-
damage, autoﬂuorescence, and a distorted detection volume
are all possible sources of error.8,12 This degradation of infor-
mation can partly be compensated for by increasing the laser
power. This may, however, induce unwanted effects like au-
toﬂuorescence, photobleaching, and optical saturation.13,14
Fluorescence recovery after photobleaching FRAP is an
alternative technique for studying diffusion.15 The basic prin-
ciple is to photobleach ﬂuorescent molecules in a chosen re-
gion of interest, and subsequently measure the rate of ﬂuores-
cence recovery. As opposed to FCS, a high concentration of
ﬂuorophores is necessary to detect the inﬂux of unbleached
molecules during recovery. FRAP has a lower time resolution
than FCS, because recovery may occur during the bleaching
period in cases of fast diffusion. FRAP is therefore better
suited for measuring slow diffusion on a time scale of milli-
seconds to seconds, whereas FCS operates best on a time
scale of microseconds to milliseconds the diffusion time win-
dow in the Confocor2 covers the range 0.2 s to 1 s.12 The
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highest diffusion coefﬁcient that can be measured with two-
photon FRAP is limited by the characteristic diffusion time
and the bleaching time. According to Meyvis et al.,16 the
bleaching time should be less than 1 /15 of the characteristic
diffusion time, but a factor of 1 /2 is also shown to be
sufﬁcient.17
Although FCS is a frequently used method for intracellular
studies,7–9,11,18 only a few FCS studies of extracellular diffu-
sion in tissue have been published.10 To our knowledge, there
are no published results on extracellular diffusion in multicel-
lular spheroids using FCS. In cellular environments, two-
photon excitation has the advantage of increased depth pen-
etration, reduced photobleaching, and a more well-deﬁned
detection volume.8,19 However, the feasibility of one-photon
FCS in living cells and tissue has been demonstrated.8,20 The
purpose of the present work was thus to explore the capabili-
ties and limitations of a one-photon FCS system ConfoCor2,
Carl Zeiss Jena GmbH, Germany to measure diffusion of
macromolecules in tissue. Diffusion of IgG and dextran mol-
ecules was measured extracellularly in multicellular sphe-
roids, as well as in gelatin hydrogel and solution, and com-
pared to previously obtained results with FRAP.17 Gel and
spheroids were used as model systems for the ECM. Due to
the structural obstacles in the ECM and interactions between
the ECM constituents and macromolecules, a single, free dif-
fusion coefﬁcient may not be sufﬁcient for characterizing dif-
fusion. In the present work, three different theoretical ﬁtting
models were therefore applied and compared.
2 Materials and Methods
2.1 Fluorescence Correlation Spectroscopy
FCS is based on recording of intensity ﬂuctuations from ﬂuo-
rescent molecules in the detection volume. Data processing
yields a correlation function that compares the signal at time t
with the signal at a short time  later. The normalized auto-
correlation function is given by12
G = 1 +
Ft · Ft + 
Ft2
=
Ft · Ft + 
Ft2
, 1
where Ft is the measured ﬂuorescence signal intensity at
time t, and Ft is the deviation from the mean signal inten-
sity Ft.
To retrieve relevant information, the correlation function is
represented by a proper mathematical model. A general ﬁtting
model for multiple diffusive species undergoing free transla-
tional diffusion in a 3-D Gaussian detection volume, including
a triplet fraction, can be described by12
G = 1 +
1
N
·
1 − T + T exp− 
T

1 − T
· 	i=1
m
i

1 +  Di
1 + 1S2 Di
1/2 , 2
where N is the mean number of particles in the detection
volume, T and T are the triplet fraction and triplet lifetime,
respectively both assumed equal for all components, i is
the fractional intensity of the i’th species, m is the total num-
ber of species in the sample, and Di is the translational dif-
fusion time of the i’th species through the detection volume.
The structure parameter,
S = z/xy , 3
denotes the ratio of the axial to the radial waist of the Gauss-
ian detection volume, deﬁned as the distances at which the
intensity drops to 1 /e2 of the maximum intensity.12
The diffusion coefﬁcient D is calculated by
D =
xy
2
4D
. 4
For anomalous diffusion, D is the apparent diffusion coefﬁ-
cient and depends on the time scale, or equivalently the length
scale, of the experiment.21 The autocorrelation function for
anomalous diffusion can be described by12
G = 1 +
1
N
·
1 − T + T exp− 
T

1 − T
·
1

1 +  
D

1 + 1S2 D
1/2 , 5
where  is the anomaly coefﬁcient. The value of  indicates
the degree of anomaly, and equals 1 for free, Brownian diffu-
sion. Obstructed diffusion is indicated by 1, and is called
anomalous subdiffusion.7,21,22
2.2 Materials and Sample Preparation
Tetramethylrhodamine TMR-dextran, MW 155 kDa
Sigma-Aldrich, Saint Louis, Missouri and 2 MDa Molecu-
lar Probes, Eugene, Oregon, and 150-kDa Alexa Fluor 546-
IgG Molecular Probes, Eugene, Oregon were used as ﬂuo-
rescent tracers. TMR and Alexa dyes are highly suitable for
FCS due to high quantum yields, photostability, and aqueous
solubility.
For maximum detection efﬁciency, concentrations of the
tracers were chosen individually for the different model sys-
tems, using a lower limit of photon count rate equal to ten
times the background signal8 of an unstained sample. Due to
difﬁculties dissolving the 2-MDa TMR-dextran molecule, the
solution was successively vortexed and heated to 37 °C be-
fore ﬁltering through a 0.45-m membrane ﬁlter Millex-HV,
PVDF, Millipore, Billerica, Massachusetts to eliminate large
aggregates. For measurements of free diffusion in solution,
the tracers were diluted in phosphate buffered saline PBS to
concentrations on the order of 10−8 M.
Bovine gelatin powder Kebo, Oslo, Norway was weighed
and dissolved in PBS to produce a hydrogel concentration of
5% w/v. Tracers were added to ﬁnal concentrations on the
order of 10−8 M, and the mixture was given a quick stir be-
fore incubation at 45 °C for at least 20 min.
Multicellular spheroids were made from the human os-
teosarcoma cell line OHS.23 Tumor cell populations of 2
106 were seeded in 75-cm2 cell culture ﬂasks Corning
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Incorporated, Corning, New York precoated with 9 ml of 1%
soft agar, and containing 25-ml growth medium RPMI-1640
supplemented with 10% fetal bovine serum, 100-units /ml
penicillin/streptomycin, and 1-mM L-glutamine all from
Sigma-Aldrich, Saint Louis, Missouri. The spheroids were
grown at 37 °C and 5% CO2. Half the growth medium was
changed after 3 days, and the spheroids were allowed to grow
for 2 more days to reach a convenient size of 150 to 250 m
diameter.24
Spheroids were transferred to tubes and tracers were added
to ﬁnal concentrations of 10−7 to 10−6 M for 155-kDa dex-
tran and 10−8 to 10−7 M for IgG and 2-MDa dextran. Several
concentrations were prepared before each experiment, and the
concentration that gave the best signal-to-noise ratio was cho-
sen. FCS measurements were performed after incubation of
the spheroids on a roller at 37 °C. The incubation time was
5 to 7 h for the smallest tracers. To ensure penetration into
the spheroids, the 2-MDa dextran was allowed 10 to 12 h of
incubation.
2.3 Experimental Setup and Optimization
of Parameters
One-photon FCS measurements were performed using the
LSM510/ConfoCor2 Carl Zeiss Jena GmbH, Germany with
a C-Apochromat 40 /1.2-W corr objective. All tracers were
excited by a 543-nm laser, and ﬂuorescence was detected
through a BP 560 to 615 ﬁlter and a pinhole diameter of
80 m 1 Airy unit.
The dimension of the detection volume for the 543 HeNe
laser line was estimated using rhodamine 6 G Sigma-
Aldrich, Saint Louis, Missouri with a known diffusion coef-
ﬁcient of 2.8·10−6 cm2 /s. The radial waist was calculated to
0.19 m using Eq. 4.
Laser powers were kept low 0.9 to 2.3 W incident on
the sample to avoid artifacts like photobleaching and optical
saturation. Photobleaching was indicated by falling baselines
in the intensity ﬂuctuation data. Saturation was investigated
for all tracers in solution, and was detected as a deviation
from linearity between the photon count rate per molecule and
laser power. Measured characteristic diffusion times remained
constant in the chosen laser power range data not shown.
To minimize the probability of having to discard data due
to tracer aggregates passing through the detection volume,
short measurement times were used 2 to 5 s. Statistics were
improved by calculating the diffusion coefﬁcients from the
average correlation function of several 5 to 30 repetitive
runs.25
The spheroids were imaged by confocal laser scanning mi-
croscopy CLSM to deﬁne the position of the FCS measure-
ments in the ECM. Cells were visualized by detecting reﬂec-
tion of the argon 488 laser through a BP 480 to 520 ﬁlter Fig.
1a, and the labeled macromolecules, which were located in
the ECM, were imaged using a HeNe 543 laser and a LP 560
ﬁlter Fig. 1b. The resulting images were sufﬁcient for lo-
calizing the extracellular space. The pixel size of the images
was 0.11 zoom 4 to 0.45 m zoom 1, i.e., the same order
as the radial dimension of the detection volume. FCS mea-
surements were typically performed in extracellular areas
with a distance of 4 to 8 m between cells Fig. 1d. The
extracellular composition has previously been characterized.26
The measurements were taken at a depth in the spheroids of
20 to 30 m. FCS could not be performed farther into the
spheroids due to scattering and absorption of light, resulting
in a low signal-to-noise ratio. Images were compared before
and after FCS measurements to exclude measurements inﬂu-
enced by movement artifacts.
2.4 Data Analysis
For the 2-MDa TMR-dextran, large peaks in the intensity
time traces due to aggregates were carefully deleted from the
raw data ﬁles. For all tracers, measurements were discarded if
the ﬂuctuation data showed a successively falling baseline, or
if the normalized autocorrelation curve was distorted in any
way. For data analysis, an anomalous ﬁtting model and a two-
component free diffusion model were applied whenever the
one-component free diffusion model gave an unsatisfactory
ﬁt. The available ﬁtting models in the LSM510/ConfoCor2
software are based on Eq. 2 and were used for one- and
two-component ﬁttings. The anomalous model based on Eq.
5 was applied using MATLAB Mathworks Incorporated,
Natick, Massachusetts gﬁt; open-source software for global
analysis of experimental data, see http://gﬁt.sourceforge.net/.
A two-sample, two-tailed student’s T-test Minitab,
Minitab Incorporated, State College, Pennsylvania assuming
nonequal variances was used to perform statistical compari-
son of the Gaussian-distributed diffusion coefﬁcients obtained
with FCS and FRAP. The Mann-Whitney test was applied
when the normality assumption was violated and the sample
size was less than 30. A signiﬁcance criterion of p	0.05 was
used. The goodness of ﬁt was quantiﬁed by R2 the correlation
index.27 To statistically compare the ﬁtting models, the dif-
ference between R2 for the two-component and the anomalous
model Rtwo-component
2
−Ranomalous
2  was calculated for each
dataset and grouped according to tracers and model systems.
The probability of this difference being equal to zero was
tested with a 95% conﬁdence interval.
Fig. 1 CLSM image of an OHS multicellular spheroid incubated with
Alexa Fluor 546 IgG. a Reﬂection of Ar 488 laser red, b emission
BP 560 to 615 nm of Alexa Fluor 546 green, and c superposition
of both images. The crosshair indicates the localization of the focal
volume. d An enlarged section of the spheroid indicates the dimen-
sions of the extracellular space.
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3 Results
3.1 Optimization and Calibration of Experimental
Setup
Optimal illumination of the samples was achieved by keeping
the laser power at a low level to minimize photobleaching and
optical saturation. Photobleaching was occasionally observed
as a falling baseline in the ﬂuorescence intensity time traces
data not shown. For all tracers in solution, saturation effects
were observed as a deviation from the linear dependence be-
tween the photon count rate per molecule and laser power,
and occurred above laser powers of 3.4 W incident on the
sample Fig. 2. Based on this, the maximum laser power used
in the FSC experiments was 2.3 W incident on the sample.
To conﬁrm that our instrumental setup was well calibrated,
the diffusion of all tracers was measured in aqueous solution
as a ﬁrst step. As expected, the one-component free diffusion
model was found to be appropriate Table 1. Fitting the
anomalous model to measurements of free diffusion in solu-
tion yielded average anomaly coefﬁcients for the three tracers
in the range of 0.910.93. Fitting a two-component
model to the same experimental data did not give interpret-
able results, as one of the components indicated unlikely fast
diffusion.
3.2 Diffusion Measurements
Representative intensity time traces for IgG and dextrans in
gel and spheroids are shown in Fig. 3. Aggregates are visible
as peaks in the ﬂuctuation data for the 2-MDa dextran. The
higher average photon count rate for measurements in sphe-
Fig. 2 Investigation of optical saturation for Alexa Fluor 546-IgG ,
155-kDa TMR-dextran , and 2-MDa TMR-dextran  in solution.
The plot shows the photon count rate per molecule as a function of
the laser power incident on the sample.
Table 1 Mean values of experimental diffusion coefﬁcients 10−8 cm2/s and standard deviations ob-
tained with FCS for IgG and dextrans 155 kDa and 2 MDa in solution, 5% gelatin hydrogel, and OHS
multicellular spheroids. For measurements in solution, the one-component free diffusion model was
used. For measurements in gel and spheroids, diffusion coefﬁcients are estimated by the two-component
free diffusion model and the anomalous diffusion model. The anomaly coefﬁcients  are presented,
together with the anomalous diffusion coefﬁcients.
System One-component free or anomalous diffusion Two-component free diffusion
D  D1 D2
150-kDa IgG
Solution 31.99±0.88 - - -
Gel 9.65±3.01 0.76±0.04 14.42±3.93 1.58±1.08
Spheroids 20.95±4.83 0.81±0.05 22.51±4.49 1.96±1.41
155-kDa dextran
Solution 18.13±1.64 - - -
Gel 5.81±1.13 0.82±0.08 16.26±8.86 2.97±1.52
Spheroids 12.68±2.79 0.86±0.09 17.28±3.65 2.77±2.07
2-MDa dextran
Solution 7.33±0.95 - - -
Gel 2.97±0.42 0.85±0.06 12.86±6.06 1.35±0.56
Spheroids 1.23±0.32 0.81±0.08 4.81±2.62 0.54±0.31
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roids reﬂects the higher concentration of tracer needed to
overcome the cellular autoﬂuorescence. Typically, the one-
component free diffusion model failed when ﬁtted to the au-
tocorrelation curves obtained from measurements in gel and
spheroids. An anomalous diffusion model and a free diffusion
model with two species were therefore applied Table 1, as
shown for IgG in Fig. 4. However, the quality of ﬁt by the two
latter models could not be distinguished based on R2.
Fig. 3 Intensity ﬂuctuations during the measurement for a and d Alexa Fluor 546–IgG, b and e 155-kDa TMR-dextran, and c and f 2-MDa
TMR-dextran in a, b, and c 5% gelatin hydrogel, and d, e, and f OHS multicellular spheroids.
Fig. 4 Autocorrelation function ……. and curve ﬁtting — by a and d one-component, b and e anomalous, and c and f two-component
model for a, b, and c IgG in 5% gelatin hydrogel and d, e, and f OHS multicellular spheroids. The goodness of ﬁt is indicated by R2, and
residuals are shown in the lower part of each panel.
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Using the anomalous model, all three tracers showed sub-
diffusive properties in both gel and spheroids. The two-
component model gave signiﬁcantly different diffusion coef-
ﬁcients for the two components. The ratios of the fast to slow
diffusing components were in the range of 5 to 11. The aver-
age populations Fig. 5 of the two diffusing components were
especially well separated for IgG. For IgG in gel, a further
separation in two groups can be seen within each component
Fig. 5a. This reﬂects the variability between gels produced
on two different days. In gel, the ratios of the diffusion coef-
ﬁcients of the fast components relative to those in solution
were 0.45, 0.90, and 1.75, and the percentage populations of
the fast components were 75
13, 50
23, and
30
13% for IgG, 155-kDa dextran, and 2-MDa dextran,
respectively. In spheroids, the ratios of the diffusion coefﬁ-
cients of the fast components relative to those in solution were
0.71, 0.95, and 0.66, and the percentage populations of the
fast components were 82
8.1, 74
16, and 42
22%
for IgG, 155-kDa dextran, and 2-MDa dextran, respectively.
Diffusion coefﬁcients obtained from the one-component
free diffusion model for solution and the anomalous model for
gel and spheroids were compared Fig. 6. The diffusion co-
efﬁcients in solution, gel, and spheroids are signiﬁcantly dif-
ferent for all tracers. The diffusion coefﬁcients for 2-MDa
dextran are signiﬁcantly lower than for the smaller molecules
in all model systems. IgG experienced a signiﬁcantly faster
diffusion than 155-kDa dextran in all model systems. The
ratios of the diffusion coefﬁcients in gel to those in solution
are approximately the same 0.30 to 0.41 for all tracers. Dif-
fusion measured extracellularly in spheroids is approximately
twice as fast as in gels for both IgG and 155-kD dextran. The
2-MDa molecule, on the other hand, experiences a markedly
retarded diffusion in spheroids. The ratios of the diffusion
coefﬁcients in spheroids to those in solution are approxi-
mately 0.66 and 0.70 for IgG and 155-kDa dextran, respec-
tively, and 0.16 for 2-MDa dextran.
3.3 Comparison of Diffusion Coefﬁcients Measured
with Fluorescence Correlation Spectroscopy
and Fluorescence Recovery after Photobleaching
Anomalous diffusion coefﬁcients determined by FCS was
compared to free diffusion coefﬁcients obtained with FRAP17
for tracers in solution, 5% gelatin hydrogel, and OHS multi-
cellular spheroids Fig. 7. The FRAP measurements, which
were previously performed in our laboratory, were best repre-
Fig. 5 Percentage populations of the fast  and slow  diffusion components obtained by ﬁtting the two-component free diffusion model for a
and d IgG, b and e 155-kDa dextran, and c and f 2-MDa dextran in a, b, and c 5% gelatin hydrogel and d, e, and f OHS
multicellular spheroids.
Fig. 6 Mean diffusion coefﬁcients with standard deviations for IgG,
155-kDa dextran, and 2-MDa dextran in solution black, 5% gelatin
hydrogel light gray, and OHS multicellular spheroids dark gray.
Diffusion coefﬁcients for measurements in solution are based on the
one-component free diffusion model, whereas the anomalous diffu-
sion model was used to estimate diffusion coefﬁcients in gel and sphe-
roids. Mean values represent 18 to 45 measurements.
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sented by the one-component free diffusion model. The dif-
ferences between the diffusion coefﬁcients estimated by the
two techniques are in the range of one standard deviation.
4 Discussion
One-photon FCS measurements of macromolecular diffusion
in solution, 5% gelatin hydrogel, and extracellularly in OHS
multicellular spheroids were successfully achieved and com-
pared to previously reported two-photon FRAP data.17 A
novel aspect is to use FCS to measure extracellular diffusion
in multicellular spheroids, which is a well-established model
for avascular tumor tissue.4,24,28,29 Whereas FRAP has been
used for this purpose,4,30 no FCS studies on extracellular dif-
fusion in multicellular spheroids have, to our knowledge, pre-
viously been published. In the present study, the main goal
was to investigate whether FCS measurements give compa-
rable results to FRAP data obtained on the same microscope,
and whether results obtained with FCS indicate anomalous or
multiphase diffusion, and thereby provide additional informa-
tion to FRAP.
4.1 Diffusion of Macromolecules in 5% Gelatin
Hydrogel Multicellular Spheroids
The diffusion coefﬁcient for dextrans decreased with increas-
ing molecular size. IgG experienced a faster diffusion than the
dextran of approximately the same size. This has been previ-
ously reported,31 and is due to the conﬁgurational difference
between the globular IgG and the linear, ﬂexible dextran.
The diffusion of IgG and dextrans in gel and spheroids was
slower than in solution, and deviated from the one-component
free diffusion model. This demonstrates that molecular mobil-
ity is subject to obstruction by the polymer network. How-
ever, tracer aggregates or a distorted Gaussian focus proﬁle
may also cause the one-component free diffusion model to
fail, giving an erroneous impression of anomalous or multi-
phase diffusion.19 To avoid distortion of the focus proﬁle, the
laser power was kept low.
Fitting of the anomalous model to autocorrelation func-
tions for all three tracers in gel and spheroids yielded anomaly
coefﬁcients close to, but signiﬁcantly different from, the
anomaly coefﬁcients measured in solution. This result is sup-
ported by a diffusion study conducted by Lead, Starchev, and
Wilkinson,32 which showed that increasing a gel concentra-
tion from 0 to 3% resulted in only a slight increase of
anomaly. Anomalous diffusion in heterogeneous systems has
been reported in several FCS studies.7,9,11,21,32–34 Various un-
derlying causes for anomalous diffusion have been suggested,
such as molecular binding of the diffusing particles,35 adsorp-
tion to chains in the structural meshwork,34 molecular
crowding,11 and infrequent and large jumps that particles
make between distinct pores in the network in which they are
constrained.36
The two-component diffusion model was successfully ﬁt-
ted to all measurements in gel and spheroids. In all cases, the
diffusion coefﬁcients of the two components were signiﬁ-
cantly different. The fastest diffusion components were found
to be of the same order as the free diffusion coefﬁcient mea-
sured in solution, hence indicating an aqueous phase. Only for
the 2-MDa dextran in gel was the fast component signiﬁ-
cantly higher than the free diffusion coefﬁcient in solution.
The slow components were ﬁve to eleven times slower than
the fast components.
It has been suggested that the interstitial space consists of
two phases; a viscous gel compartment and a free-ﬂuid space,
which offers less resistance to interstitial transport,37,38 thus
supporting the relevance of the two-component model. FCS
has also revealed a two-phase diffusion process in tumors.10
However, in complex and heterogeneous environments like
the interstitium, molecules may aggregate, bind to structures
of various sizes, or be trapped in compartments. Diffusion
may thus be more diverse than what can be represented by the
two-component model.
To determine whether diffusion is anomalous or if there
are, in fact, two components diffusing with different speed,
would give valuable information about the structural geom-
etry of the ECM and interactions between the ECM and the
diffusing particles. However, based on visual inspection of the
curve ﬁts and the corresponding residuals, together with a
statistical analysis of R2, it was not possible to conclude
which model gives a true representation of the diffusion pro-
cess. This is in accordance with previous ﬁndings of molecu-
lar dynamics in complex systems.7,9,33 On the other hand, sev-
eral factors suggest that the two-component model is less
reliable, the lack of a visible two-component shape of the
autocorrelation curve, the unlikely high diffusion coefﬁcient
of the fast component for 2-MDa dextran in gel, and the large
standard deviations for the mean diffusion coefﬁcients calcu-
lated from the two-component model Table 1. The fact that
the anomalous model ﬁts the data equally well with a lower
number of variables further suggests that this model is more
robust.
4.2 Relevance of Tissue Models
Gelatin hydrogel mimics the structural collagen network in
the ECM, and the multicellular spheroid represents a 3-D in-
Fig. 7 Mean diffusion coefﬁcients calculated from FCS and FRAP
measurements of IgG gray, 155-kDa dextran white, and 2-MDa
dextran black in solution circle, 5% gelatin hydrogel square, and
OHS multicellular spheroids triangle. Standard deviations are indi-
cated by error bars. The one-component free diffusion model was
used for FRAP in all model systems and for FCS in solution, whereas
the anomalous diffusion model was applied for FCS in gel and sphe-
roids. Mean FCS values represent 18 to 45 measurements. FRAP mea-
surement of FITC-IgG in spheroids was not obtained due to internal-
ization of the labeled molecules into the cells.
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vitro model of an avascular tumor.28 A gelatin gel of 5% has a
density of collagen ﬁbers comparable to the collagen content
in the ECM of tissue, which is reported to be 0.2 to 2%.39,40
The collagen concentration in OHS multicellular spheroids,
however, has been measured to 0.05% unpublished data.
Also other multicellular spheroids have been shown to have
ten times less collagen content compared to the corresponding
xenografts growing in vivo.4 In the present study, diffusion is
clearly more obstructed in gel than in spheroids for IgG and
155-kDa dextran. However, in contrast to the two smaller
molecules, the 2-MDa dextran experiences a slower diffusion
in the ECM than in gel. This indicates that up to a certain size,
the particles are mainly retarded because of their molecular
shape and increased viscosity of the solvent. For the 2-MDa
molecule, however, the size of the particle relative to the mesh
size of the geometrical network provides an additional retard-
ing factor. The ECM is therefore a more severe barrier for
larger molecules.
4.3 Fluorescence Correlation Spectroscopy
Compared to Fluorescence Recovery
after Photobleaching
One-photon FCS data were compared to results previously
obtained with two-photon FRAP.17 The FCS measurements
revealed both anomalous and two-component diffusion, which
were not detectable in the FRAP study. This demonstrates that
FCS is a more sensitive technique than FRAP, and provides
information with a higher time resolution. The anomaly coef-
ﬁcients for the FCS data indicate little deviation from free
diffusion, and we therefore assume that the anomalous diffu-
sion coefﬁcients can be compared to the free diffusion coef-
ﬁcients obtained with FRAP. Except for the 2-MDa molecule,
diffusion coefﬁcients from FCS measurements equal the
FRAP diffusion coefﬁcients within the range of one standard
deviation. This demonstrates that although the two methods
differ in principle and in practical applications, FCS and
FRAP can be applied to the same system within a certain time
scale of the molecular dynamics.
FCS and FRAP are both based on ﬂuorescence detection,
and are commonly used in diffusion studies.4,10,11,18,33,39 There
are, however, several fundamental differences between the
two methods, making them suitable for different purposes.
FRAP is based on equilibrium perturbation by photobleaching
of a predeﬁned area with a high laser intensity and subse-
quently detecting the inﬂux of unbleached tracers. The pho-
tobleaching process may induce uncharacterized chemical and
biological disturbances in the sample. In FCS, the system is in
equilibrium throughout the FCS measurement, and pho-
tobleaching is avoided by using low laser intensities. This
implies that the two techniques require ﬂuorophores with dif-
ferent photostability. In addition, whereas one single particle
is detectable in FCS, high concentrations are required to per-
form a FRAP experiment. FCS is thus less invasive than
FRAP when studying living tissue, because substantially less
chemical substance is injected and no perturbation of the sys-
tem occurs. For measuring immobile fractions, FRAP is a
better suited technique because FCS cannot detect immobile
or very slowly moving particles. For small particles in solu-
tion, the diffusion is too rapid for FRAP detection, but ideal
for FCS. Another advantage of FCS over FRAP is that it is a
more versatile technique, giving information about transla-
tional and rotational diffusion, triplet fractions, interactions,
and concentrations.
5 Conclusion
The present work demonstrates that one-photon FCS is suit-
able for measuring diffusion of macromolecules extracellu-
larly in tissue. One-photon FCS and two-photon FRAP17 mea-
surements on the LSM510/ConfoCor2 gave comparable
diffusion coefﬁcients. In addition, FCS revealed a two-phase
or an anomalous nature of the transport in gel and spheroids,
which was not possible to detect with FRAP performed on the
same microscope.
FCS is an important technique for studying the delivery of
macromolecules in cancer therapy. The method may provide
information about the interactions and transport barriers ex-
tracelluarly as well as intracellularly.18 FCS and related
techniques41–44 are constantly being reﬁned, and are valuable
tools for investigating fundamental processes in molecular
biology.
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FCS multi-component free diffusion fitting model.
Assuming a 3D Gaussian detection volume, the general multi-component free diffusion 
fitting model is described by 
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where N  is the mean number of particles in the detection volume, T and TU  are the triplet 
fraction and triplet lifetime, respectively (both assumed equal for all components), i'  is the 
fractional intensity of the ith species, m is the total number of species in the sample, and 
iD
U
is the characteristic diffusion time of the ith species through the detection volume. For m=1,
Eq. (1) is reduced to the one-component free diffusion model. xyX  and zX  are the axial and 
the radial waist of the Gaussian detection volume, respectively, defined as the distances at 
which the intensity drops to 1/e2 of the maximum intensity.   
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Abstract
Despite growing interest in chitosans as gene delivery vehicles, the understanding of the 
structure-function relationship is still incomplete. Here, we have systematically varied the 
degree of interaction between the chitosan and its pDNA cargo by controlling i) chain length of 
the chitosan and ii) degree of hindrance, and examined the influence of these parameters on 
gene transfer. For this purpose, we have prepared series of six low molecular weight chitosans 
with constant charge density and a degree of polymerization (DPn) in the range of 21 – 88 (Mw 
4.7 – 33 kDa). Using these chitosans, we have studied the relationship between the chain length 
and formulation properties, cellular uptake of polyplexes, and gene transfer efficacy. At a given 
amino-phosphate (A/P) ratio, the various chitosans complexed pDNA into nanoparticles of 
comparable size and surface charge which showed similar cellular uptake but highly variable 
transfection efficacy. The maximum gene expression was achieved with DPn31 – 42 and an 
increase in chain length and A/P ratios reduced and delayed luciferase expression. The gene 
transfer pattern correlated with the heparin induced unpacking of polyplexes. Substituting the 
chitosan by uncharged oligosaccharides weakened the interaction with pDNA and reduced or 
enhanced transfection efficacy, depending on the DPn and A/P. The more stable polyplexes, the 
higher increase in transfection efficacy was achieved after substitution. Furthermore, the 
magnitude of gene expression was also controlled by the size of the substituent. Confocal laser 
scanning microscopy (CLSM) and fluorescence correlation spectroscopy (FCS) investigation of 
intracellular trafficking and dissociation of the polyplexes did not provide any direct evidence of 
differences in polyplex unpacking but demonstrated that the polyplexes were internalized as 
large aggregated structures and were transported to the nucleus. FCS revealed that chitosan 
molecules were diffusing in the cytoplasm and nucleus. Altogether, these findings suggest that 
the chitosan-mediated gene delivery may be controlled by modulation of the interaction strength 
between the chitosan vector and its plasmid cargo which determines the timing and extent of 
polyplex disassembly.  
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Introduction
Chitosans, linear copolymers of ȕ-1-4 linked N-acetyl-D-glucosamine (GlcNAc) and D-
glucosamine (GlcN), are naturally derived cationic polysaccharides that are highly attractive as 
drug and gene delivery candidates [1-3]. The interest in chitosan is related to its availability, 
excellent safety profile, biodegradability, ease of modification as well as unique biological 
properties. Due to its polycationic nature, chitosans spontaneously self-assembly with nucleic 
acids to form nanosized complexes that may be employed for gene delivery. Since chitosan is a 
weak polybase with the pKa of 6.6 [4, 5], the charge density of chitosan depends on pH and 
implies that chitosan may be regarded as a pH-responsive polymer. High charge density of 
chitosan below pKa may be beneficial for polyplex preparation and escape from endocytotic 
vesicles, whereas low charge density at pH 7.4 contributes to low cytotoxicity and may facilitate 
intracellular pDNA release. However, the low charge density at physiological pH also leads to 
low solubility, aggregation and poor stability of chitosan-based formulations depending on type 
of chitosan used. The majority of the chitosan-mediated gene delivery studies are performed 
with a few off-the shelf chitosans of given composition and properties. Bearing in mind that the 
family of chitosans spans over a range of polymers with highly variable properties, it is clear 
that different chitosan samples may give highly variable outcome in a particular application. On 
the other hand, understanding of the structure-property relationship will open for tailoring of 
chitosans with optimal properties for a given application.  
General consensus is that a successful polymer-based gene transfer requires a subtle balance 
between sufficient DNA protection and intracellular DNA release which reflects the degree of 
interaction between the gene carrier and its DNA cargo [6-8]. Therefore, the structure of the 
polymer carrier (charge density, chain length) and stoichiometry of the complexes are key 
determinants of the transfection efficacy. A clear correlation between chain length of the 
polymer and transfection efficacy has been reported for poly-L-lysine (PLL) [8] and 
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polyethylenimine (PEI) [9, 10] but conflicting results may be found for chitosan [7, 11-13]. 
Although a few studies promote the use of high molecular weight (Mw) chitosans [11, 13, 14], 
the chitosans of lower Mw seem to be superior for gene delivery [7, 12]. It has been shown that 
the chitosan with Mw of 10 kDa and fraction of acetylation (FA) 0.08 – 0.2 seemed particularly 
efficient compared to 40 kDa chitosan and higher Mw [12]. On the other hand, chitosan 
oligomers below 5 kDa and FA 0 showed poor gene delivery in vitro [7, 15]. Based on the data 
available, it seems that the optimal chitosans for gene delivery have Mw in the range of 5 – 40 
kDa. This range of molecular weights has not been systematically investigated yet and we have 
hypothesized that by creating a series of chitosans with chain lengths within this range and 
studying their gene transfer capabilities, the optimum chain length may be revealed with finely 
tuned balance between DNA protection and polyplex unpacking.  
Apart from chitosan chain length, the degree of interactions between chitosan and DNA may 
also be controlled by targeted derivatisation inducing hindrance. Our recent work with glycosylated 
chitosans revealed that the substitution of chitosan with uncharged GlcNAc-containing trimers 
weakened the binding interactions but increased transfection efficacy [16, 17].  
The overall goal of this study was to gain insights into the structure-function relationship in 
chitosan-mediated transfection. We hypothesized that polyplex disassembly depends on the 
degree of interaction between chitosan and its pDNA cargo which may be controlled by the 
chitosan design. To test this hypothesis, we have prepared series of low molecular weight 
chitosans with constant charge density where we systematically varied i) degree of 
polymerization (Mw 4.7 – 40 kDa) and ii) degree of hindrance, and examined the influence of 
these parameters on gene transfer. Using these chitosans, we have studied the relationship 
between the chain length and formulation properties, cellular uptake, gene transfer efficacy, and 
intracellular trafficking. Furthermore, systematic substitution of chitosans with GlcNAc-
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containing oligosaccharides has been performed to create series with variable degree of 
substitution, degree of polydispersity, and size of substituents. Studying the structure-activity 
relationship across the series verified that the charge-based interaction between chitosan and 
pDNA and thereby the gene transfer efficacy may be controlled by tailoring of the chitosan 
structure.
Materials and methods 
Cell culture. Human embryonic kidney cell line HEK293 was obtained from ATCC (Rockville, 
MD) and cells between passage nr. 39 and 60 were used in all experiments. The HEK293 were 
grown in MEM (Gibco Invitrogen) supplemented with 1 mM of non-essential amino acids and 
10 % fetal bovine serum (FBS) (Gibco Invitrogen) at 370C and 5 % CO2.
Plasmid DNA. Reporter plasmids (gWizTMLuc and gWizTMGFP) (approximately 6.7 kb) 
containing a cytomegalovirus promoter (CMV) and firefly luciferase (Luc) or green fluorescent 
protein (GFP) were purchased (Aldevron, Fargo, ND). When indicated, plasmid DNA was 
labeled by YOYO-1 (Molecular Probes, Eugene, OR) using a molar ratio of 1 dye molecule per 
100 base pairs at room temperature in the dark. 
Chitosans. Chitosan oligomers with number average degrees of polymerization (DPn) in the 
range of 21 – 88 were prepared by nitrous acid depolymerization of fully de-N-acetylated 
chitosan (FA < 0.002, Mw 146 kDa) as described earlier [18]. To obtain desired chain length, the 
amount of sodium nitrite were varied from 0.02 to 0.14 mol/mol GlcN. To prepare the 
substituted oligomers (TCO), depolymerized chitosans were then reduced by NaBH4 and 
reductively N-alkylated with the trimer 2-acetamido-2-deoxy-D-glucopyranosyl-ȕ-(1-4)2-
acetamido-2-deoxy-D-glucopyranosyl-ȕ-(1-4)-2,5-anhydro-D-mannofuranose (A-A-M) as 
described previously [19]. All TCO samples were characterized by 1H-NMR to determine the 
degree of substitution. The average degrees of polymerization and chain length distributions for 
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both series were analyzed by size-exclusion chromatography (SEC) with refractive index (RI) 
detector (Dawn Optilab 903, Wyatt Technology Corp., CA) and a multiangle laser light 
scattering detector (MALLS, Dawn DSP, Wyatt Technology Corp., CA) [20]. All samples were 
dissolved in Milli-Q (MQ) water (5 – 7 mg/mL) and filtered through 0.22 μm syringe filter 
(Millipore Corp., MA). The column used was TSK 3000 PWXL, and the sample was eluted 
with 0.2 M ammonium acetate (pH 4.5) at a flow rate of 0.5 mL/min. For simplicity, the linear 
chitosan oligomers are denoted as linear whereas the trisaccharide substituted chitosan 
oligomers are denoted as TCO. The characteristics of the chitosans used in the study are given 
in Table 1. 
When indicated, a low-molecular-weight chitosan with a number average DPn21 was 
fractionated by size-exclusion chromatography on Superdex 30 columns into fractions 
corresponding to DP intervals of 10 – 15, 16 – 22, 23 – 27 and 28 – 50. 
For CLSM and FCS, chitosan was labeled by Alexa Fluor 647 carboxylic acid, succinimidyl 
ester (Molecular Probes, Eugene, OR) using a molar ratio of 1 dye per 200 glucosamine 
residues. The transfection efficacy of labeled chitosans was comparable to that of unlabeled 
chitosans.
Solubility of chitosans. 0.05 mL aliquots of 2 mg/mL solution of chitosans in MQ water were 
transferred to 96-well plate and diluted to 0.1 mL by double strength Hanks balanced salt 
solution (HBSS, Gibco Invitrogen) supplemented with 20 mM HEPES (Sigma-Aldrich, MO) 
with pH in the range of 6.5 – 8.0. After 1 h incubation at room temperature and shaking, the 
absorbance of the solution was measured at 400 nm on TECAN Safire2 (Tecan Austria GmbH, 
Austria).
Preparation of chitosan/pDNA polyplexes. Polyplexes with different amino/phosphate (A/P) 
ratios and pDNA concentration of 13.3 μg/mL were prepared by the self-assembly method. The 
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constant amount of pDNA solution (0.5 mg/mL) was diluted in MQ water and then required 
amount of sterile filtered chitosan stock solution in MQ-grade water (2 mg/mL) was added 
during intense stirring on a vortex mixer (1200 rpm). The complexes were incubated for 30 
minutes at room temperature prior to transfection.  
Size and surface charge analysis. The size of the chitosan/pDNA polyplexes was determined 
by dynamic light scattering on a Zetasizer Nano Zs (Malvern Instruments, UK). The 
measurements were performed at an angle of 1730 and a temperature of 25oC and each sample 
was analyzed in triplicate. The size of the polyplexes is expressed as mean diameter (z-average) 
obtained by cumulant analysis of the correlation function using the viscosity and refractive 
index of water in the calculations. For measurements of aggregation kinetics, the polyplexes 
were diluted 1:2 with double HBSS pH 7.0 to obtain the isotonic formulations similarly as in 
transfection experiments, and the size was repeatedly measured over a period of 120 min. 
Surface charge (zeta potential) was determined by Doppler velocimetry on the same instrument. 
Gel retardation assay. The pDNA retention capacity of the polyplexes and heparin induced 
release of pDNA was studied using gel electrophoresis. The polyplexes were prepared as 
described above at a constant pDNA concentration of 13 μg/mL and A/P ratios of 5, 10, 20, and 
30 and incubated for 30 min. Next, the polyplexes were diluted 1:2 in transfection medium with 
and without 100 μg/mL heparin and incubated at 37oC and 5 % CO2 for 4 h and overnight, 
respectively. After incubation, 10 μL of the complex solution was mixed with 5 μL of loading 
buffer and loaded on 0.8 % agarose gel containing 0.5 μg/ml ethidium bromide (EtBr). The gel 
electrophoresis was run in 40 mM Tris-acetate-EDTA (TAE) buffer at pH 7.4 at 80 V for  
45 min. 
In vitro transfection experiments. HEK293 cells were seeded in 96-well tissue culture plates 
24 h prior to the transfection experiments to obtain cell confluency of 80 – 90 % on the day of 
transfection. The polyplexes formulated in MQ water were diluted 1:2 by OptiMEM (OptiMEM 
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I, Gibco Invitrogen) supplemented by 270 mM mannitol and 20 mM HEPES to adjust 
osmolality and pH. Cells were washed with pre-heated OptiMEM and 50 μL of isotonic 
formulation containing 0.33 μg pDNA was added to each well. After 5 h of incubation, the 
formulations were replaced by 200 μL of fresh culture medium (MEM, 10 % FBS). Culture 
medium was changed every second day. To determine luciferase expression, cells were washed 
twice with pre-heated PBS, lysed with luciferase lysis buffer (Promega) and the luciferase 
activity (expressed in relative luciferase units, RLU) was measured on a luminometer 
(Molecular Devices, CA). The total cell protein was determined by bichinchoninic acid assay 
(Pierce).
Flow cytometry. Flow cytometry analysis of GFP expressing cells or polyplex uptake with 
YOYO-1 labeled pDNA was performed using a BD LSR1 (Becton Dickinson, San Jose, CA). 
Cells were incubated with YOYO-1 labeled polyplexes for 3 h and washed twice with 1 mg/mL 
heparin solution to dissociate and remove cell surface associated complexes. Cells expressing 
GFP were analyzed 48 h after transfection. Prior to flow cytometry analysis, cells were washed 
twice in PBS, trypsinised, resuspended in ice-cold PBS supplemented with 2 % FBS and kept 
on ice. For each sample, 10 000 events were counted and a dot plot of forward light scatter 
against side scatter was used to establish a collection gate to exclude the cell debris and dead 
cells showing reduction in the forward scatter as well as aggregates of cells. The GFP or 
YOYO-1 positive cells were excited by 488 nm laser line and detected using a 530/30 nm band 
pass filter. To distinguish between autofluorescence and fluorescently labeled cells, non-
transfected cells were run as negative controls. The percentage of cells expressing GFP was 
calculated and the relative amount of expressed GFP was estimated from the median 
fluorescence intensity of GFP positive population. The cellular uptake of the polyplexes was 
calculated as the percentage of YOYO-1 labeled cells and the relative amount of internalized 
pDNA was estimated from the median fluorescence intensity of YOYO-1 positive population.  
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Confocal laser scanning microscopy (CLSM). HEK293 cells were seeded on 8-chambered 
microscopic slides (Ibidi GmbH, Germany) and transfected as described above. After 2 h of 
incubation at 37oC and 5 % CO2, live cells were examined using LSM 510 (Carl Zeiss Jena 
GmbH, Germany) with a C-Apochromat 40x/1.2 W corr objective. The cell nuclei were stained 
by incubating the cells with 5 μg/mL Hoechst 33342. YOYO-1 and Alexa Fluor 647 were 
excited by 488 nm argon laser line and 633 nm HeNe laser line, respectively and the emitted 
light was detected through BP500-550 and LP650 filter. Hoechst 33342 was excited using two-
photon excitation obtained by a modelocked Ti:Sapphire laser (Mira Model 900-F, coherent 
Inc., Laser Group, Santa Clara, CA, USA) at 780 nm. 
Fluorescence correlation spectroscopy (FCS). FCS measurements were performed using the 
LSM 510/Confocor2 (Carl Zeiss Jena GmbH, Germany) with a C-Apochromat 40x/1.2 W corr 
objective as previously described [21]. Briefly, Alexa Fluor 647 was excited using a 633 nm 
HeNe laser line and the emitted light was filtered through a LP650 filter before being collected. 
A pinhole diameter of 90 μm was used. The point of interest in a cell (either in the nucleus or in 
the cytoplasm) located 3 to 8 μm above the cover glass was chosen using confocal microscopy. 
The point of interest was bleached for 20 seconds previous to measurements to eliminate 
possible noise caused by cell autofluorescence or by completely immobilized fluorescent 
molecules. Autocorrelation curves were obtained by performing 5 measurements for 15 seconds 
at the point of interest and analyzed as previously described [22] using the two-component free 
diffusion model provided by the Confocor2 software. The apparent concentration was defined 
as the observed number of particles in the detection volume divided by the detection volume. 
The size of the detection volume was calibrated as previously described. [21] 
Statistical analysis. All measurement data were collected and expressed as mean values ± 
standard deviation (SD). Statistical differences between mean values were investigated using 
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ANOVA in conjunction with a multiple comparison test (Tukey test). Differences between 
means were considered significant at p  0.05. 
Table 1 Characterization of chitosan samples used. The molecular weights (Mw, Mn) and 
molecular weight distribution were analyzed by SEC-MALLS. The degree of substitution (d.s.) 
of A-A-M was determined by 1H NMR.
Sample FA linear TCO
Mn Mw PDI Mn Mw PDI d.s.
DPn21 < 0.002 4200 4700 1.12 5000 6000 1.20 8.0 
DPn31 < 0.002 6300 8000 1.28 7100 9800 1.36 7.8 
DPn42 < 0.002 8500 11600 1.37 9900 14100 1.42 7.8 
DPn54 < 0.002 10800 16400 1.52 12800 20100 1.56 7.5 
DPn72 < 0.002 14500 24800 1.71 17600 30100 1.71 7.8 
DPn88 < 0.002 17600 32900 1.87 21800 39500 1.81 7.6 
DPn400 < 0.002 85900 146000 1.70 102000 174000 1.71 8.3
Results
Effect of chain length on gene transfer efficacy of chitosan 
To investigate how the chain length of chitosan affects transfection efficacy, a series of low 
molecular weight chitosans was prepared and used as gene carriers for transfection of HEK293 
cells. After preliminary screening of optimal A/P ratios for all chitosans (data not shown), three 
to four formulations with A/P ratios from 3 to 20 were prepared from each chitosan and 
compared for luciferase gene expression. As reported previously [17], transfection efficacy of 
chitosan oligomers is highly pH-dependent and impaired at pH 7.4 and the experiments were 
thus performed at pH 7.0. The results presented in Fig. 1a,b show that both the DPn and the A/P 
ratio clearly affected transgene expression. The polyplexes formed by DPn31 and DPn42 
mediated the highest luciferase expression in HEK293 at 48 h (Fig. 1b). For all chitosans, gene 
expression varied with the composition of polyplexes given by the A/P ratio. Generally, the 
transgene expression increased with increasing A/P ratio to a certain point and then declined. 
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This effect was most pronounced for the shortest and longest oligomers in the series, DPn21 and 
DPn88. The optimal A/P ratio depended on the chain length of chitosan following a general 
trend showing the higher DP, the lower the optimal A/P ratio. The luciferase gene expression 
mediated by the non-degraded original chitosan sample with DPn 400 (Mw 146 kDa) at any A/P 
ratio was far below the levels obtained with the depolymerized chitosans. Furthemore, 
comparison of the total cellular protein levels in cell lysates during the luciferase analysis 
revealed similar extent of cell proliferation, and thereby no differences in relative toxicity of the 
formulations. 
To compare transgene expression on a single cell level, the HEK293 were transfected with an 
identical plasmid carrying GFP instead of luciferase and the percentage of GFP expressing cells 
in the population was determined 48 h after transfection as shown in Fig. 1c. Despite large 
differences in luciferase production, all oligomers showed close to 50 % of transfected cells at 
optimal A/P ratios. The percentage of transfected cells decreased at suboptimal A/P ratios for all 
formulations.  
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Figure 1 Transfection efficacy of depolymerized chitosans in HEK293 cells. a) Luciferase gene 
expression 48 h after transfection using polyplexes formed with chitosans with degrees of 
polymerization (DPn) from 21 to 400 and amino-phosphate (A/P) ratios of 3 – 20. b) Results of 
a) plotted as a function of degree of polymerization of chitosan. c) Percentage of GFP 
transfected cells 48 h after transfection. All data points represent mean ± SD, n = 4. 
Formulations yielding efficiency significantly different from the DPn31 formulation at A/P 10 
are indicated by an asterisk (n = 4, p < 0.05). 
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Fig. 1 shows transfection efficacy at 48 h after transfection. To examine whether the different 
chitosan formulations exhibited different transgene expression kinetics, the time course of the 
luciferase expression was measured. As shown in Fig. 2, the kinetics of transgene expression 
was influenced by the A/P ratio. In case of DPn31 (Fig. 2a), the formulations with A/P 3 and 5 
mediated the highest expression at 48 – 72 h and then the luciferase production declined. On the 
contrary, in cells transfected with formulations with A/P 10 and 30, luciferase levels 
continuously increased up to 96 h. Similar trends in transgene expression kinetics were found 
for DPn31 and DPn88, but the total luciferase production was substantially lower after 
transfection with DPn88.  
time (h)
0 20 40 60 80 100 120 140 160 180
lu
ci
fe
ra
se
 g
en
e 
ex
pr
es
si
on
 
(R
LU
/ 
g 
pr
ot
ei
n)
0
100
200
300
400
500
600
A/P 1.5 
A/P 3 
A/P10 
A/P30 
time (h)
0 20 40 60 80 100 120 140 160 180
lu
ci
fe
ra
se
 g
en
e 
ex
pr
es
si
on
(R
LU
/ 
g 
pr
ot
ei
n)
0
500
1000
1500
2000
2500
A/P 3 
A/P 5 
A/P 10 
A/P 30 
a)
b)
Figure 2 Time course of luciferase gene expression in HEK293 cells transfected by a) DPn31 
and b) DPn88 at different A/P ratios. Data points represent mean ± SD, n = 4. 
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Physicochemical characterization of polyplexes 
To scrutinize the reasons for variable efficacy of depolymerized chitosans, we examined the 
sequence of events during a transfection experiment to reveal in what stage of the transfection 
process the chain length is important.  
Supplementary Figure S1 pH-dependent solubility of chitosan in HBSS measured as 
absorbance at 400 nm (A400). 
The complexation of pDNA by chitosan was carried out in MQ water at pH < 5.5 to assure full 
solubility of chitosans (see Fig. S1 in supporting information), strong electrostatic interactions, 
and large entropic contribution driving the formation of complexes. Under these conditions, all 
depolymerized chitosans (DPn21 – DPn88) at A/P 5 formed polyplexes with z-average diameter 
in the range of 60 – 70 nm and zeta potential of 18 ± 6 mV. The diameters of polyplexes slightly 
increased with increasing chain length from 59.6 ± 2.5 nm for DPn21 to 69.9 ± 3.1 nm for 
DPn88. The chitosan with DPn400 formed larger polyplexes, approximately 85 ± 4 nm. The size 
of polyplexes remained stable from about a few minutes after preparation to at least 2 weeks 
after preparation, provided storage in MQ water (data not shown).  
Prior to cell transfection, the polyplexes were diluted with hypertonic medium (OptiMEM with 
20 mM Hepes and 270 mM mannitol, 590 mM) in order to obtain isotonic formulations. In 
agreement with a previous report, polyplexes rapidly aggregated in transfection medium but were 
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still able to transfect the cells [16, 17]. To examine possible chain length influence on the extent of 
aggregation, we have compared the kinetics of aggregation of all polyplexes at A/P 5. Fig. 3 shows 
that following dilution of polyplexes in transfection medium, all complexes rapidly aggregated 
into micrometer large structures. The degree of aggregation slightly increased with increasing DPn.
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Figure 3 Time-dependent aggregation of polyplexes formed by linear chitosans with DPn21 – 
400 at A/P 5 following dilution in HBSS at pH 7.0 (final concentration of pDNA 6.6 μg/mL). 
Cellular uptake of polyplexes 
The aggregation of polyplexes leads to increased sedimentation of polyplexes on the cell 
surface. To compare the degree of uptake of polyplexes by HEK293 cells, internalized 
polyplexes labeled by YOYO-1 were determined by flow cytometry after extensive washing of 
the transfected cells by medium containing 1 mg/mL of heparin. Almost all cells internalized 
the polyplexes, each formulation was taken up by 95 ± 2 % cells. The exceptions were 
polyplexes of DPn21 at A/P 10 and DPn400 at A/P 10 which were internalized only by 85 % 
cells. Naked pDNA (pWizLuc) was detected in 40 % cells. Although the percentage of YOYO-
1 positive cells was similar for all chitosans and A/P, the amount of internalized pDNA 
determined from median fluorescence intensity levels varied as shown in Fig. 4a. Cells 
transfected with naked pDNA and DPn21 at A/P 10 exhibited extremely low fluorescence. The 
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highest fluorescence levels were measured in cells transfected by DPn72 and 88 at A/P 3. 
Interestingly, formulations with higher A/P ratios showed lower amounts of internalized pDNA. 
As shown in Fig. 4b, there was no apparent correlation between the uptake of pWizLuc and 
luciferase gene expression.  
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Figure 4 Uptake of YOYO-1 labeled polyplexes in HEK293. The percentage of YOYO-1 
positive cells and the median of fluorescence intensity (FI) was determined by flow cytometry. 
a) median FI of YOYO-1 positive cells transfected by different chitosan formulations and b) 
correlation between pWizLuc uptake and expression. Data points represent mean ± SD, n = 4. 
Polyplex dissociation 
Bearing in mind the lacking correlation between the uptake of polyplexes by HEK293 cells and 
transfection efficacy, the differences in relative transfection efficacy of chitosans seem to result 
a)
b)
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from different intracellular fate of the polyplexes. Clearly, the chain length of the polycation and 
the amount of polycation in the polyplex are crucial factors governing the stability of the 
polyplex. To compare the pDNA retention ability under transfection conditions, the polyplexes 
were incubated in transfection medium at 37oC for 4 h and then subjected to gel electrophoresis 
at pH 7.4. As shown in Fig. 5A, with exception of the polyplexes formed by DPn21 at A/P 5 and 
10, all polyplexes were stable and retained all complexed pDNA. To mimic intracellular 
conditions, the polyplexes were incubated overnight in the transfection medium supplemented 
by 100 μg/mL heparin as a competing polycation. As shown in Fig. 5b, pDNA was released 
from all complexes formed at A/P 5 and 10 except those formed by DPn400. The extent of the 
release of pDNA decreased with increasing A/P of the formulation and chain length of the 
chitosan. Whereas formulations prepared from DPn21 released almost all pDNA at all A/P, 
polyplexes formed by DPn54 and DPn88 retained all pDNA at A/P 20. Interestingly, pDNA 
released from the polyplexes showed lower fractions of supercoiled conformation and higher 
fractions of open circular form compared to naked pDNA. 
a)
b)
12345678910111213141516
Figure 5 Stability of chitosan/pDNA polyplexes elucidated by gel electrophoresis. Complexes 
with chitosans with DPn 21, 31, 54, 88 and 400 and A/P 5, 10, 20 were incubated in Optimem at 
37oC for a) 4 h and b) overnight in presence of 100 μg/mL heparin and subjected to gel 
electrophoresis in TAE buffer at pH 7.4. Lane 1: naked pDNA, lane 2 – 4: DPn21 at A/P 5, 10, 
20, lane 5 – 7: DPn31 at A/P 5, 10, 20, lane 8 – 10: DPn54 at A/P 5, 10, 20, lane 11 – 13: DPn88 
at A/P 5, 10, 20, lane 14 – 16: DPn400 at A/P 5, 10, 20. 
a)
b)
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Gene transfer efficacy of glycosylated chitosans: effect of chain length  
To further strengthen the hypothesis that it is the interaction strength between pDNA and 
chitosan that determines the gene transfer efficacy, we have prepared a series of trimer 
substituted chitosan oligomers (TCO) and compared the effect of chain length and A/P ratio 
before and after substitution. Fig. 6 shows the transfection efficacy in the series of TCO (8 % 
d.s) differing in chain length.
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Figure 6 Transfection efficacy of glycosylated oligomers in HEK293 cells. a) Luciferase gene 
expression 48 h after transfection. b) Comparison of linear and TCO oligomers at A/P 10. c) 
Relative transfection efficacy (TCO/linear) as a function of A/P ratio. 
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Compared to unsubstituted oligomers (Fig. 1a), there is a noticeable shift towards higher 
effective A/P ratios for short oligomers, i.e. more polycation had to be used to complex pDNA. 
As demonstrated in Fig. 6a, several formulations showed a comparable transfection efficacy, 
however at widely differing A/P ratios; DPn31 at A/P 60 was equal to DPn54 at A/P 5. The 
interval of optimal transfection efficacy was broader for TCOs than that for linear oligomers and 
the effect of A/P was less dominating.  
Fig. 6b shows the comparison of transfection efficacies of linear oligomers and TCOs at a 
constant A/P ratio of 10. The effect of A-A-M substitution on transfection efficacy is strictly 
dependent on the chain length of the chitosan. In case of shorter oligomers such as DPn21 and 
31, the substitution resulted in a dramatic decrease or even a complete loss of activity, whereas 
it increased the efficacy of chitosans over DPn42. The longer the chain, the higher increase in 
transfection efficacy after substitution. Similarly, the positive effect of glycosylation is more 
apparent at higher A/P ratios as shown in Fig. 6c.  
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Figure 7 Luciferase gene expression in HEK293 cells transfected with fractionated TCO with 
DPn21. TCO21 was fractionated into four different fractions DP 10 – 15, DP 16 – 22, DP 23 – 
28 and DP 28 – 50 using gel permeation chromatography. The original chitosan oligomer 
(DPn21) is shown in black and the fractionated chitosans are shown in grey. 
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Clearly, the substitution of DPn21 almost completely eliminated gene transfer. To investigate 
the critical chain length necessary to mediate transfection, TCO21 was fractionated by gel 
permeation chromatography into defined fractions of DP 10 – 15, 16 – 22, 23 – 28 and 28 – 50. 
These fractions were then substituted by A-A-M and evaluated as gene carriers. As shown in 
Fig. 7, the transfection efficacy exponentially increased with increasing chain length and A/P 
ratio and only the fraction containing the chains in the range of DP 28 – 50 showed efficient 
delivery. The unfractionated original sample DPn21 had one order of magnitude lower 
transfection efficacy than the fraction containing chains with DP 28 – 50. Apparently, only the 
chitosan chains above 28 monomer residues were able to mediate transfection.
Effect of the length of substituent  
To confirm the crucial role of well-balanced interactions between chitosan and pDNA, we chose 
two depolymerized chitosans with average DPn34 and DPn88 and synthesized a systematic 
series of glycosylated chitosans where we varied the length of the substituent from dimer A-M 
to pentamer A-A-A-A-M. Gel electrophoresis assay confirmed that the polyplex stability 
decreased with the length of the substituent (data not shown). Fig. 8 shows that the effect of 
substitution is strongly linked to the charge ratio and the length of the chitosan backbone. For 
polyplexes formed by DPn34 (Fig. 8a) at A/P higher than 10, the substitution of chitosan by the 
dimer and trimer increased transfection efficacy whereas the pentamer substitution decreased 
transfection efficacy. At A/P 10, gene transfer efficacy was negatively influenced by 
glycosylation and luciferase expression was found to decrease with increasing size of the 
substituents. For DPn88 (Fig. 8b), all substitutions improved gene transfer efficacy. The 
maximum luciferase expression was achieved with trimer- and pentamer-substituted chitosans, 
with the latter less sensitive to A/P ratio.  
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Figure 8 Transfection efficacy of glycosylated DPn34 (a) and DPn88 (b) in HEK293 cells. 
Chitosans were substituted with dimer (A-M), trimer (A-A-M) and pentamer (A-A-A-A-M) at a 
degree of substitution of 7 % .  
CLSM and FCS 
To elucidate the intracellular polyplex stability and transport within the cells, HEK293 cells 
were transfected with polyplexes that were double-labeled with YOYO1 and Alexa Fluor 647, 
and imaged by CLSM to investigate whether and where they remained intact or disintegrated 
within the cells. Chitosans DPn31 and DPn88 were used as delivery vehicles based on the highly 
different transfection efficacy of their respective polyplexes at A/P 10. 
CLSM images were acquired of living cells transfected by polyplexes formed by DPn31 (Fig. 
9a,b) and DPn88 (Fig. 9c,d). The polyplexes were clearly aggregated and large structures were 
a)
)
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observed both inside and outside the cells, especially for DPn88. For both chitosans, it was 
possible to find cells where most of the pDNA appeared free (Fig. 9b,d) as well as cells where 
large chitosan aggregates but no pDNA were seen (Fig. 9a,c). There was a larger variation within 
a cell population treated by the same polyplex than between the different chitosan formulations. 
Apparently, the cells internalized the polyplexes and both pDNA (free and chitosan-associated) 
and free chitosans were found in the nucleus approximately 1 h after transfection.  
Figure 9 CLSM images of HEK293 cells transfected with polyplexes formed by chitosans 
DPn31 (a,b) and DPn88 (c,d). Chitosans were labeled by Alexa Fluor 647 (red) and pDNA by 
YOYO-1 (green). The cell nuclei were labeled with Hoechst 33342 (blue). The bar size is 10 μm. 
To obtain more quantitative characterization of the dynamics of the intracellular transport of 
polyplexes to the cytoplasm and nucleus, FCS was used to measure the diffusion times and 
determine the apparent concentration of Alexa Fluor 647-labeled chitosans. The essential pre-
requisite for FCS is that the measured molecules are mobile, i.e. free to diffuse through the 
excitation volume. Therefore, low mobility of free pDNA as well as the autofluorescence of 
HEK293 cells complicated the measurements of YOYO-1-labeled pDNA, which emits 
a) b) 
c) d) 
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fluorescence in the same spectral interval as autofluorescence. Thus only chitosan could be 
tracked by FCS. Intracellular trafficking of both polyplexes and free chitosan were studied, and 
in both cases the experimental autocorrelation curves were well fitted by the two-component 
free diffusion model, demonstrating a fast and slowly diffusing population. The fast and slow 
diffusion coefficients, D1 and D2, presented in Table 2 are representative of diffusion in 
cytoplasm and nucleus 1 h and 24 h after incubation with either free chitosans or polyplexes. 
The fast diffusing population in cells incubated with polyplexes is probably free chitosan as the 
diffusion coefficient is equal to the fast diffusion coefficient measured in cells incubated with 
free chitosan. This diffusion coefficient was lower than the diffusion of chitosan measured in 
solution (data not shown), demonstrating that the diffusion of the chitosans are somewhat 
hindered intracellularly. The slow diffusion coefficient D2 was attributed to chitosan bound to 
cellular components or pDNA. Because of the similarity of D2 after incubation with free 
chitosan and polyplexes, it was not possible to distinguish whether chitosan was bound to 
cellular components or to pDNA in cells after incubation with polyplexes. 
Table 2 Diffusion coefficients of free chitosan and polyplexes in HEK293 nucleus 24 h after 
transfection. The diffusion coefficients were calculated from FCS autocorrelation functions 
analyzed with a two-component free diffusion model. 
Diffusion coefficients of free 
chitosan (×10-12m2s-1)
Diffusion coefficients of polyplexes
(×10-12m2s-1)
Sample
D1 ± SD D2 ± SD D1 ± SD D2 ± SD 
DPn31 51.7 ± 5.1 5.7 ± 0.6 46.3 ± 3.8 4.8 ± 0.6 
DPn88 61.8 ± 2.3 6.2 ± 0.5 57.0 ± 3.6 4.3 ± 1.1 
Analysis of autocorrelation curves enabled determination of the apparent intracellular 
concentration of chitosan in the excitation volume. Fig. 10 compares the concentration of 
chitosans DPn31 (Fig. 10a) and DPn88 (Fig. 10b) in HEK 293 cytoplasm and nucleus, 1 h and 
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24 h after incubation with either free chitosans or polyplexes. Apparently, the cells internalized 
more chitosan after incubation with polyplexes than with free DPn31 and DPn88. The amounts 
of internalized DPn31 and DPn88 in cytosol and nucleus seem to be comparable when measured 
1 h after incubation of cells with free chitosan. On the contrary, when incubating HEK 293 cells 
with polyplexes, differences were observed in the accumulation of DPn31 and DPn88. Only 
polyplexes of DPn88 showed intranuclear accumulation after 24 h. The same amount of 
polyplexes of DPn31 was found in the nucleus at the two time points, whereas the concentration 
of the slowly diffusing population increased in the cytoplasm.  
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Figure 10 Apparent concentrations of chitosans DPn31 (a) and DPn88 (b) in the cytosol and 
nucleus of HEK293 cells 1 h and 24 h after incubation with free chitosan or polypexes. 
Significant differences in the apparent concentrations of bound chitosan and/or polyplexes after 
1 h and 24 h incubation are indicated by an asterisk while significant differences in the apparent 
concentrations of freely diffusing chitosan after 1 h and 24 h incubation are indicated by two 
asterisks.
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Discussion 
Despite numerous reports on the use of chitosan for gene delivery, the understanding of the 
relationship between the structure of chitosan and its transfection efficacy is still incomplete. 
The transfection efficacy has been shown to depend on molecular weight [7, 11, 12], chemical 
composition [12, 14, 23, 24], pH [24], and serum presence [25], but the reported results are not 
always consistent and there is a lack of consensus what are the ideal molecular parameters and 
conditions for efficient transfection as well as rational explanation for these. The discrepancy 
may be partly explained by poor availability of suitable samples with precisely defined 
molecular structure and differences in the formulation properties. Here, we have performed a 
systematic structure-function study on chitosan-mediated gene transfer to test the hypothesis 
that it is the strength of charge-based interaction with pDNA which determines the polyplex 
dissociation and thereby the magnitude of gene transfer with chitosan. By precise tuning of the 
chitosan properties such as the chain length and the extent of hindrance, ideal balance between 
pDNA protection and release may be obtained, leading to high gene transfer efficacy. 
We have previously shown that chitosan oligomers in the range of DPn 18 – 25 mediated more 
efficient gene transfer than high Mw chitosan (210 kDa) but had still relatively low gene 
expression in vitro compared to 25 kDa PEI [7]. To improve the transfection efficacy, 
derivatisation strategies based on glycosylation have been developed [16, 17, 26]. Although 
having lower gene transfer efficacy than the glycosylated chitosans, the linear low molecular 
weight chitosans with constant charge density and Mn in the range of 4 – 20 kDa used in this 
study, represent an ideal model system to study the role of charge-based interaction with pDNA 
in chitosan-mediated gene transfer. The transfection efficacy of linear oligomers clearly 
depended both on chitosan chain length (DPn) as well as its amount available for complex 
formation (A/P) (Fig. 1a). As the DPn is proportional to the valency of the polycation and the 
A/P ratio is proportional to the total number of charges, these results highlight the principal role 
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of charge-based interactions [27]. Similarly as for low molecular weight linear PEIs [9], it was 
possible to compensate for lower affinity by increasing the amount of charges to a certain 
degree, as decreasing chain lengths lead to higher amounts of chitosan necessary to form a 
functional polyplex and vice versa. However, we were able to identify a narrow interval of 
chain lengths between DPn 30 – 40 (Mn 6.3 – 8.5 kDa) mediating superior transgene expression 
irrespective to the A/P ratio (Fig. 1b). Interestingly, comparing the magnitude of transgene 
expression with the percentage of transfected cells indicates that the differences between 
different chitosans are due to the higher protein production rather than the amount of cells 
which were transfected (Fig. 1c). The differences in transfection efficacy cannot be explained 
by the differences in the size and surface charge of polyplexes or the cellular uptake of the 
formulation. The missing correlation between cellular uptake of polyplexes and transgene 
expression (Fig. 4b) indicates that increased transfection efficacy of chitosans with DPn30 – 40 
is due to more efficient cellular processing of the delivered pDNA rather than the more efficient 
delivery of pDNA into the cells. 
Comparing the kinetics of transgene expression for eight different formulations based on 
chitosan DPn31 and DPn88 (Fig. 2) showed that increasing the amount of chitosan above the 
optimal A/P lead not only to lower gene expression, but also delayed the onset of transgene 
production. Combining the results in Fig. 1 and 2, it is possible to hypothesize that chitosans 
with DPn 30 – 40 produce polyplexes with optimal pDNA binding strength which show optimal 
unpacking kinetics intracellularly whereas increasing the chain length and A/P of formulation 
lead to tighter polyplexes which exhibit slower and less efficient pDNA release. This is 
supported by a recent report where polyplexes formed by high molecular weight chitosan (390 
kDa) showed slow unpacking kinetics [6] as well as previously reported data showing 
correlation between chitosan structure and polyplex stability [28-30]. Furthermore, general 
correlation between transfection efficacy and heparin-induced pDNA release was found in this 
study (Fig. 5). Formulations not able to release pDNA after heparin treatment, such as DPn400,
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showed poor transfection efficacy. On the other hand, formulations showing premature 
dissociation in transfection medium such as DPn21 at A/P < 10 showed both low cellular uptake 
and low transfection efficacy.  
Due to the interest in glycosylated chitosan, we decided to investigate the chain length effect 
also in the series of trimer substituted chitosans (TCO) prepared by grafting the uncharged 
trisaccharide A-A-M to the linear chitosans described above. The presence of the substituent 
induces hindrance and weakens the affinity between pDNA and TCOs, yielding polyplexes 
which release pDNA more easily than the polyplexes of unsubstituted chitosans. Consequently, 
it may be expected that A-A-M substitution of short chitosans forming unstable complexes such 
as DPn21 will reduce the transfection efficacy, whereas the substitution of long chitosans 
forming too stable complexes such as DPn88 will enhance the gene delivery. Indeed, the results 
in Fig. 6 confirmed this assumption and further strengthen the primary role of chitosan-pDNA 
interaction strength in chitosan-mediated transfection. As shown in Fig. 6b,c the longer the 
chain and the more stable polyplexes, the stronger enhancement of the transfection efficacy after 
glycosylation. The same is true about the A/P ratio (Fig. 6c), the reduced stability of complexes 
following glycosylation may be compensated by higher amount of polymer available.  
The differences in the influence of A/P ratio on transfection efficacy observed for linear (Fig. 1) 
and TCO chitosans (Fig. 6) further support the critical role of charge-based interactions. The 
nitrous acid degradation of chitosan produce polydisperse samples and the polydispersity index 
increases with DPn (see Table 1). This means that at given A/P, the polyplexes are formed by 
mixture of chains with variable chain length. With increasing A/P ratio, increased amounts of 
chitosan and higher amounts of longer chains are available in the formulation, yielding more 
stable polyplexes. Therefore, in case of linear chitosan (Fig. 1), transfection efficiency 
drastically decreased above the optimal A/P ratio similarly as it does when the chain length 
increases. However, in case of TCOs (Fig. 6), this effect was counterweighted by hindrance 
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imposed by uncharged substituent and despite chain length, the polyplexes were still able to 
disassembly. This was confirmed in the experiment with TCO21 fractionated into narrow DP’s 
(Fig. 7), where the transfection efficacy of the TCO with DP > 28 was 10-fold higher than the 
parent sample and TCO with DP below 28 were practically inefficient. Apparently, the TCO 
samples contain large fraction of short chains which are unable to yield competent polyplexes, 
necessitating the need of high A/P ratios. The importance of charge-based interactions was 
further emphasized in the experiment where the strength of the chitosan-pDNA interaction was 
controlled by the size of the substituent and the degree of substituent grafting.  
The confocal laser scanning microscopy of cells transfected by polyplexes DPn31 and DPn88 at 
A/P 10 did not reveal any substantial differences in polyplex unpacking or intracellular 
trafficking of DPn31 versus DPn88 polyplexes. HEK293 cells were able to internalize large 
aggregates of complexes (Fig. 9) similarly as reported by Ishii et al [31], and cells transfected by 
DPn88 appeared to contain larger aggregates compared to those transfected by DPn31. CLSM 
was able to detect merely the large assemblies of fluorescent molecules of the entire transfected 
cells. FCS measurements in the nucleus and cytoplasm revealed that free chitosan was present 
in both compartments 1 h post incubation with complexes. We have previously shown that 
polyplex formulation of linear chitosan at A/P 10 contain typically about 50 % of free unbound 
chitosan [21] and this free chitosan also enters the cells together with polyplexes. However, 
HEK293 cells internalized more chitosan after incubation with polyplexes than with free 
chitosan. The presence of the chitosan in the cytosol and nucleus indicates that chitosan and 
polyplexes are able to escape lysosomal degradation and are transported to the nucleus. Even 
though the accumulation of slowly diffusing DPn31 inside the cytoplasm 24 h post transfection 
might be attributed to a dissociation of the polyplexes in the cytoplasm, it is not clear whether 
the accumulation of free and bound DPn88 in the nucleus is more likely due to a partial binding 
of free DPn88 following a migration of free DPn88 from the cytoplasm to the nucleus and/or to a 
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dissociation of the polyplexes in the nucleus. Therefore future FCS work should focus on the 
intracellular fate of pDNA rather than of chitosan.  
Conclusion
A better understanding of the structure-function relationship in chitosan-mediated gene delivery 
is important for future design of chitosan-based delivery systems. Here we have shown that by 
varying  the chain length of the chitosan and the degree of hindrance, it is possible to control the 
degree of interaction between the chitosan and its pDNA cargo in the polyplex and thereby the 
magnitude of the gene transfer. The gene delivery efficacy depended strongly on the valency of 
the chitosan and maximum transgene expression was achieved in a narrow optimal window of 
DPn31 – 42. The differences between different chitosans were due to more efficient protein 
production rather than the amount of cells which were transfected. Increasing chain length and 
A/P above the optimum, both reduced and delayed the transgene expression. Furthermore, 
introduction of hindrance reduced or enhanced transfection efficacy, depending on the DPn,
A/P, size of the substituent, and degree of grafting. These findings provide evidence that the 
transfection efficacy is governed by the interaction strength between the chitosan vector and its 
plasmid cargo in the polyplex which determines the timing and extent of polyplex disassembly.  
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Abstract
Solid tumors are characterized by abnormal organization, structure, and function of 
blood vessels. These abnormalities give rise to enhanced vascular permeability and may 
predict therapeutic response. Permeability and architecture of the microvasculature were 
measured in human osteosarcoma tumors growing in dorsal window chambers in mice 
by confocal laser scanning microscopy (CLSM) and dynamic contrast enhanced MRI 
(DCE-MRI). 40 kDa dextran and Gadomer were used as molecular tracers for CLSM 
and DCE-MRI, respectively. The volume transfer coefficient Ktrans estimated by DCE-
MRI and the extravasation rate Ki measured by CLSM were found to correlate. This 
demonstrates that the two techniques may give complementary information. 
Extravasation was related to the microvascular structure and was found to correlate with 
fractal dimension, vascular volume fraction, and vascular density. The vascular 
structural parameters were higher for the abnormal tumor vasculature than for normal 
vessels.
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Introduction 
The blood supply in tumors plays a critical role in cancer therapy. The flow rate, 
vascular structure, and permeability are responsible for the microenvironment 
characterized by hypoxia and acidosis.1,2 The vasculature and microenvironment 
determine the efficacy of radiotherapy and chemotherapy, as well as drug delivery to 
solid tumors. Most tumors develop their vascular network by angiogenesis, and the 
tumor vasculature differs markedly from that of the host tissue. Tumor vasculature has 
abnormal structure and function characterized by complex branching patterns, tortuous 
and bending vessels, and heterogeneous spatial distribution. These characteristics result 
in high geometric resistance to blood flow, leading to both spatial and temporal 
heterogeneous blood flow rate.2-5
The heterogeneity of the tumor vasculature also includes the vessel wall. In general, the 
capillary wall is poorly developed with fenestrae between the endothelial cells, a 
discontinuous endothelial cell layer, and partly lacking basal lamina, resulting in leaky 
blood vessels. However, parts of the vessel wall may also resemble normal vessels, 
contributing to the heterogeneous vessel permeability. The high permeability favor the 
transcapillary transport of therapeutic macromolecules,2,6 and delivery of novel 
nanomedicine such as proteins and encapsulated drugs or genes benefits from the 
increased permeability. Although extravasation of macromolecules in tumors may be 
enhanced compared to normal vessels, the macromolecules face severe problems 
penetrating the extracellular matrix and reaching their targets. Thus, the uptake of 
nanomedicine in tumor tissue is low and the therapeutic macromolecules are 
heterogeneous distributed.7,8 The vascular permeability is shown to depend on the tumor 
type as well as the molecular weight and charge of the molecular tracer.9-11 Structural 
parameters, such as vascular density and fractal dimension, can be used to characterize 
complexity of tumor vasculature.12,13 Fractal dimension describes irregularly tortuous 
contours and branching structures which are characteristic for tumor microvasculature, 
and it has been shown that the fractal dimension calculated by the box-counting method 
is higher for tumors than for normal microvasculature.14,15
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The crucial effect of the vasculature on the microenvironment and cancer therapy 
illustrates the need for methods to study the vascular structure and permeability. MRI is 
a non-invasive imaging technique commonly used to study the structure and function of 
the vasculature.16-18 Tracer kinetic analysis of contrast-enhanced images allows 
estimation of physiological parameters such as blood volume, blood flow and vessel 
permeability.19 However, MRI does not have sufficient spatial resolution to visualize 
cellular and subcellular structures. Intravital optical microscopy using confocal laser 
scanning or two-photon microscopy has superior spatial resolution, and several cellular 
and extracellular characteristics can be imaged simultaneously and colocalized in three 
dimensions.20,21
The purpose of the present work was to compare vascular parameters obtained with 
confocal laser scanning microscopy (CLSM) and dynamic contrast enhanced MRI 
(DCE-MRI) to investigate how these techniques may complement each other. The 
heterogeneous tumor microvascularity caused by inadequate blood perfusion22 induces a 
high degree of uncertainty in the quantification of structural and transport parameters. 
The uncertainty can be reduced by validation and cross-comparison of results obtained 
by the two imaging techniques. The dorsal window chamber allows direct examination 
of in vivo tumor angiogenesis and microcirculation over several days. Tumors were 
grown in dorsal window chambers in athymic mice, and microvasculature and 
permeability to 40 kDa dextran and Gadomer were studied by CLSM and DCE-MRI, 
respectively.
Materials and methods 
Animals and tumor model. Dorsal window chambers in MRI-compatible material 
(POM: poloxy methylene) were produced. The total weight of the camber including the 
window was 2.0 gram. The chambers were implanted on the back of 7 – 9 weeks old, 
athymic female BALB/c nu/nu mice with 23 – 25 gram of weight (Taconic, M&M, 
Denmark) as described previously.21 24 h after the implantation of the chamber, the 
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cover slip was removed and 1.5 × 106 human osteosarcoma cells from the cell line 
OHS23 were placed into the center of the chamber. A new glass cover slip was placed 
above and the chamber was closed. The xenografts were allowed to grow for two weeks 
before starting the experiments. All surgical procedures were performed under sterile 
conditions. During this period the animals were given 64 mg/kg/day Baytril 
(Enrofloxacin) in drinking water containing 2% sucrose. At the time of the experiments, 
the tumors were approximately 0.5 mm thick and filled the whole window area. The 
mice were anesthetized by subcutaneous injection of Fentanyl/Midazolam/Haldol/sterile 
water (3:3:2:4) at 12 ml/kg body weight (Hameln Pharmaceuticals, Germany, Alpharma 
AS, Norway, and Janssen-Cilag AS, Norway) and the tail vein was cannulated to allow 
injection of molecular tracers. The animals were kept under pathogen-free conditions at 
a constant temperature 19 - 22DC, humidity 50 - 60%, 65 air changes an hour, and were 
allowed food and water ad libitum. All animal experiments have been carried out with 
ethical committee approval. Mice with dorsal window chambers but without tumors 
implanted were used to study normal tissue. A total of 16 mice were included in the 
experiments. One mouse was used for high resolution MR imaging of blood vessels, the 
others were used for CLSM and DCE-MRI. Some measurements were rejected because 
of image artifacts.  
Tracers. The MRI contrast agent Gadomer (Bayer Schering Pharma AG, Berlin, 
Germany) was kindly provided by Dr. Hans Bauer. Gadomer contains 24 Gd ions at the 
surface of a dendritic backbone and has a molecular weight of about 17 kDa. However, 
due to its globular shape the apparent molecular weight is about 30 - 35 kDa. Gadomer 
has low toxicity and is mainly eliminated by glomerular filtration.24 It is large enough to 
insure slow diffusion through the vascular wall.25 For the CLSM time series, 40 kDa 
TMR(tetramethylrhodamine)-dextran (Sigma-Aldrich, St. Louis, MO) was used as a 
fluorescent macromolecule as this molecule has approximately the same molecular 
weight as Gadomer. TMR is photostable and suitable for dynamic imaging. 2MDa 
FITC(fluorescein isothiocyanate)-dextran (Sigma-Aldrich, St. Louis, MO) was used as a 
blood pool marker.  
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Confocal laser scanning microscopy 
Experimental setup. The animal was anesthetized and an overview image of the tissue 
was obtained using a stereomicroscope (Motic SMZ-168 Stereo Zoom Microscope, 
Motic Deutschland GmbH, Germany). The tail vein was cannulated and 100 lμ  of 20 
mg/ml 2 MDa FITC-dextran was injected to visualize the vascular structure. The 
cannula was flushed with 250 U/ml heparin (Sigma Chemical CO, St. Louis, MO) to 
avoid blood clotting. The animal was placed on the stage of the microscope (LSM Meta 
510, Zeiss, Jena, Germany). The body temperature was kept at 37 °C. Images with a 
field of view of 460.7 × 460.7 2mμ and 512 × 512 pixel resolution (pixel size 0.9 ×
0.9 2mμ ) were acquired with a Plan-Neofluar 20 0 5/ .×  objective. Z-stacks of the 
blood vessels were acquired using a 488 nm laser, a BP500-550 nm filter in front of the 
detector, and a pinhole diameter of 94 mμ . Extravasation of 40 kDa TMR-dextran was 
measured in three regions of interest (ROI) in each tumor. Background images before 
injection and time series after injection of 40 kDa dextran were acquired in each ROI 
using the 543 laser, an LP560 filter in front of the detector, and a pinhole diameter of 86 
mμ . 100 lμ  of 30 mg/ml 40 kDa TMR-dextran was then injected and images of the 
ROIs were successively acquired during a time period up to 60 min.  
Image post-processing and data analysis. To minimize contributions to the signal from 
other sources than the molecular tracer, the background image taken before injection of 
40 kDa dextran was subtracted from the time series acquired post injection. Intra- and 
extravascular image analysis were performed by applying motion-corrected vascular 
masks to the time series. Contours of the blood vessels were manually traced in Adobe 
Photoshop CS (Adobe Systems Inc, San Jose, CA). The extravascular area in the ROI 
was defined as all space more than 4 mμ  from the blood vessel walls. By visual 
inspection, the distance of 4 mμ  was considered sufficient to avoid fluorescence 
contribution from the intravascular area. Intensity as a function of time was measured 
for both intra- and extravascular areas using the ImageJ (version 1.38, available from 
NIH, http://rsb.info.nih.gov/ij/) plug-in Time Series Analyzer.
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The apparent permeability of the vasculature was calculated using the method described 
by Patlak et al.26 This method is based on plots of the ratio of extravascular to 
intravascular concentration of the tracer against a modified time axis (Patlak plot). We 
assumed that the concentration was proportional to the fluorescence intensity. The 
values along the ordinate axis are given by 
( )
( )
t
vess
C t
y
C t
=  (1) 
where ( )tC t  and ( )vessC t  are the extra- and intravascular concentrations at time t. The 
modified time axis is defined by 
( )
( )
vess
vess
C t dt
T
C t
= ¨  (2) 
When there is a net irreversible accumulation of fluorescence in the tissue over the time 
course of the experiment, the plot becomes linear after equilibrium is reached. The 
terminal slope of the straight line is equal to the rate constant describing the net 
irreversible transport of the fluorescent tracer from the capillaries to the extravascular 
space. An exponential function 
( )( )Tf (T ) T 1 e MB C = +   (3) 
which increases linearly with T when T is large, was fitted to the 
extravascular/intravascular intensity ratio plotted as a function of T. The slope C  of the 
straight line was used as an estimate of the extravasation rate iK .
27 In order not to 
violate the requirement of a net irreversible accumulation, only the first 35 minutes of 
the measurements were plotted. 
iK  is related to the apparent vascular permeability P  by 
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=i
SK P
V
 (4) 
where S is the vascular surface area contained in the imaged tissue volume V.
The extravasation rate was also estimated by the initial rate of accumulated fluorescence 
in the extravascular space. The fluorescence intensity in the extravascular space 
normalized to the maximum intensity was plotted versus time. For plots that did not 
reach a maximum during the measurement time, the maximum intensity was estimated 
by extrapolation of the experimental data. The initial slope of the fluorescence intensity-
time plots was defined as the extravasation rate and obtained by linear regression to the 
initial linear increase in the intensity.  
Analysis of microvascular structure was based on binary images of the vascular masks. 
Fractal dimension D was determined using Fractal Box Count in ImageJ, which counts 
the number of boxes of an increasing size needed to cover a one pixel binary object 
boundary. D is calculated from the slope (D = -slope) of a log-log plot of the box size 
and the number of boxes necessary to cover the boundary. The method was verified by 
comparing measured fractal dimensions of known fractals to theoretical values, which 
were found to be in good agreement. Fractal theory and its relevance for vascular 
networks are previously described.12,13
Vascular branching and length, diameter, and volume of each blood vessel in the 
imaged ROIs were estimated using the software Amira (Visage Imaging GmbH, 
Germany) after tracing the blood vessels with the filament editor. The number of 
branching points, also called the fork density12 (FD), is an estimate of the number of 
neo-formed vessels and was defined as the number of nodes in the filament traced 
vessels in the image. The vascular density fraction (VD) was calculated as the area of 
the image covered by vessels per total area.12 The surface area (S) was calculated as the 
sum of the surface areas of all vessels in the ROI. Because the diameter of most vessels 
was wider than the detected optical section (4.5 mμ ), the shape of a blood vessel was 
approximated as a rectangular prism instead of a cylinder.  
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MRI
Experimental setup. MRI was performed at 7T using a Bruker Biospec Avance 70/20 
(Bruker Biospin, Ettlingen, Germany) with a 72-mm volume coil for transmission and an 
actively decoupled quadrature rat head surface coil for receive only. The animals were 
anesthetized and cannulated and placed prone in the magnet on a dedicated animal bed with 
the chamber positioned in the isocenter. The body temperature was kept at 37 - 38DC with 
circulating water within the animal bed. Pilot scans were applied to localize the appropriate 
tissue within the chamber, and to perfectly align the slice plane with the chamber.  
For DCE-MRI a T1-map was obtained using a spin echo Rare (RareVTR) sequence 
with TR = 150, 600, 1200, 3000, 10000 ms, and TE = 12.5 ms. The image resolution 
was 578 × 578 2mμ , the slice thickness 0.3 mm, and the acquisition time 7 min 58 s. 
The dynamic series was acquired using a T1-weigthed spin echo Rare sequence with TR 
= 200 ms, TE = 7 ms, 2 averages. The field of view was 37 × 37 mm2 with 64 × 64 
pixel resolution (pixel size 578 × 578 2mμ ) and 350 repetitions were used. The time 
resolution was 6.4 s, with a total acquisition time of 37 min 20 s. 0.2 mmol/kg Gadomer 
was injected during the 9th repetition, over a period of 10 s.
For imaging of blood vessels, 0.2 ml 20 mg/ml AlbuminGd-DTPA ( 92 kDa) was 
injected. AlbuminGd-DTPA was synthesized in our lab based on a procedure originally 
described by Ogan.28 A T1-weighted 3D Flash (fast low flip angle shot) sequence was 
applied with TR = 15 ms, TE = 2.4 ms, and flip angle = 25.0 deg. The voxel size was 
145 × 145 × 144 3mμ and the acquisition time was 16.38 min. 
Data analysis. T1-values and the DCE-MRI data were analyzed using in-house software 
written in MatlabR2007b (MathWorks Inc, MA). T1 was estimated using least-squares 
fitting of the multi-TR recording to the standard spin-echo signal equation. A two-
compartment kinetic model19 was fitted to the concentration curves. Tofts model 
assumes that the tissue consists of a plasma compartment and an extravascular 
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extracellular space (EES), and that the rate constants kpe (transfer rate from blood to 
EES) and kep (transfer rate from EES to blood) are identical.  
The concentration ( )pC t  at time t of the contrast agent in the plasma compartment is 
determined by 
( ) ( )1 20 1 2t tpC t A a e a eB B = +  (5) 
where 0A  is the intravenously administered dose of the contrast agent. The arterial input 
function constants were previously estimated to 1a  = 6.427 kg/l, 2a  = 2.392 kg/l, 1B  = 
0.2270 min–1, and 2B  = 0.0258 min
–1 from Gadomer plasma decay for nude mice 
reported by Verhoye et al.30
The total tissue concentration ( )tC t  of the contrast agent as a function of time is given by 
( ) ( )
( )
1 2
1 2
1 2
1 2 1 2
1 2 1 2
trans
e
t t trans
t p
K /v tt t
trans trans trans trans
e e e e
C t v a e a e K
a a a ae e e
K /v K /v K /v K /v
B B
B B
B B B B
 
 
= × + + ×
  ¯ ¬­¡ °­+ + + ­¡ ° ­    ®¡ °¢ ±
 (6) 
where pv  is the plasma volume fraction, ev  is the EES volume fraction, and 
trans
ep eK k v=  is the volume transfer constant between plasma and EES.  
The ROI was defined from post-contrast images as the volume in the chamber window 
where signal enhancement was detected. Gadomer is not assumed to enter the cells and 
the extravascular compartment therefore equals EES. The Gadomer relaxivity at 7T was 
set to 7 mMí1 sí1 (personal communication, Bayer Schering Pharma AG, Berlin, 
Germany, March 2009). The volume transfer constant Ktrans was estimated by least-
squares fitting with Eq. (6) to the concentration curves. Under permeability-limited 
conditions, Ktrans equals the permeability surface area product per unit volume of 
tissue.19 Accumulation in the tissue was estimated by the time-to-peak (TTP), i.e. the time 
from injection of Gadomer until the concentration-time curve reaches its maximum. 
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Statistics
A two-sample, two-tailed Student’s T-test (Minitab, Minitab Inc., State College, PA) 
assuming non-equal variances was used to perform statistical comparison of normal and 
tumor data with a significance criterion of Pb 0.05. Correlation was investigated by 
comparing parameter values obtained for a given animal with other parameters obtained 
for the same animal. For CLSM, these values were the mean of 1 - 3 measurements at 
different ROIs in the animal. For DCE-MRI, only one ROI per animal was analyzed. 
The parameter values were plotted and correlation was estimated by applying linear 
regression. The goodness of linear fit was estimated by the coefficient of determination 
R2 and correlation was established with a significance criterion of Pb 0.05.
Results
Vascular permeability 
Extravasation of 40 kDa dextran and Gadomer in OHS tumors and normal tissue was 
monitored by acquiring time series of CLSM and DCE-MRI images, respectively, of the 
same animal on two subsequent days. Three localizations in the tissue were successively 
imaged by CLSM for a time period up to 60 min after injection of dextran. The dextran 
molecules were quickly distributed in the vasculature (Fig. 1A) and extravasated from 
the blood vessels to the extravascular space, as detected by enhancement of 
fluorescence intensity in the extravascular area (Fig. 1B and C) with time. Pre- (Fig. 
1D) and post-contrast (Fig 1E and F) DCE-MRI were acquired for the whole chamber 
window. At time 5 min post-contrast (Fig. 1E), signal enhancement due to accumulation 
of Gadomer in the tissue was observed. By the end of the experiment the signal 
intensity was almost back to pre-contrast level (Fig. 1F). 
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(A)  (B)                    (C) 
(D)  (E)                    (F) 
Figure 1. Dynamic time series of OHS tumor in a dorsal window chamber in mice, acquired by CLSM 
(A-C) and DCE-MRI (D-F). CLSM images acquired at t = 2 min (A), t = 9 min (B), and t = 25 min (C) 
after injection show fluorescence intensity enhancement due to extravasation of the 40 kDa TMR-dextran 
from the blood vessels and accumulation in the extravascular space. Images from DCE-MRI time-series 
at pre-contrast (D), t = 5 min (E) and t = 37 min (F) after injection of Gadomer show accumulation of the 
contrast agent in the tumor tissue. The pixel size was 0.9 ×  0.9 2mμ  and 578 ×  578 2mμ  for CLSM and 
DCE-MRI, respectively. 
For CLSM images, the total field of view (460.7 × 460.7 2mμ ) was used as ROI. 
Segmentation of the blood vessels allowed analysis of fluorescence intensity with time 
for both the intra- and the extravascular space in the ROIs. During the time course of the 
experiment, the intensity signal in the extravascular space increased with time, generally 
reached its maximum, and then slowly decreased again (data not shown). The 
intravascular concentration showed a rapid increase in intensity due to distribution of 
the tracer in the vasculature, followed by a gradual decrease due to clearance and 
μ100 m μ100 m μ100 m
2 mm2 mm2 mm
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extravasation of the tracer out of the blood vessels. The ratio of the intra- and 
extravascular intensity were plotted against a modified time axis in a Patlak plot (Fig 
2A) and the terminal slope of the fit was used as an indicator of permeability.27 For a 
time course of 35 min a straight line was generally well fitted to the terminal slope, and 
the estimated extravasation rate Ki was significantly different for tumor and normal 
tissue. However, the terminal slope for normal tissue was negative (data not shown) and 
normal tissue was therefore excluded from further analysis. The apparent permeability P
describes extravasation rate per vessel surface area. The initial slope of the fluorescence 
intensity-time curves was also used as an estimator of vascular permeability (Fig. 2B). 
All relevant mean values and standard deviations are listed in Table 1.
Kinetic parameters were estimated from the DCE-MRI data by fitting Tofts model to 
the Gadomer concentration-time curves in pre-defined volume ROIs. The mean T1 for 
all tumors was used as input into the Tofts model. The volume transfer constant Ktrans
describes apparent permeability, and tumor uptake was estimated by the time-to-peak 
(TTP) post-contrast. All mean values are listed in Table 1. Differences between normal 
and tumor tissue could not be detected by DCE-MRI. A typical tissue concentration-
time curve is shown in Fig. 2C. Gadomer extravasated from the blood vessels into the 
tissue, and the concentration-time curves consisted of combined clearance and 
accumulation of the contrast agent in the tumor tissue. The concentration of Gadomer 
increased and reached a maximum after 6.2 min (TTP) on average, and then subsequent 
decreased due to clearance from both plasma and the extravascular space.  
Figure 2. Different models for estimating apparent permeability. (A) Patlak-plot and (B) estimate of 
initial slope from CLSM time-series of 40 kDa dextran fluorescence intensity. (C) Tofts model fitted to 
DCE-MRI curve showing concentration versus time after injection of Gadomer. 
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Microvascular structure 
Structural parameters, including vascular density (VD), vascular volume fraction (VVF),
fork density (FD), and fractal dimension (D), was quantified from CLSM images based 
on binary images and filament traces of masked blood vessels. There was a striking 
difference between the tortuous tumor vessels (Fig. 3A) and the well organized normal 
blood vessels (Fig. 3B). To obtain high spatial resolution of the MR images of the blood 
vessels, a longer acquisition time was required and a larger intravascular contrast agent 
(AlbuminGd-DTPA) was therefore used. Larger blood vessels were clearly visualized 
(Fig. 3C). 
(A) (B) (C) 
Figure 3. Blood vessels in a dorsal window chamber imaged by CLSM (A,B) and MRI (C). (A) 
Abnormal, tortuous OHS tumor vessels and (B) well-organized normal vessels visualized in Amira by 3D 
volume rendering of CLSM z-stacks of tissue after injection of 2 MDa FITC-dextran. (C) Maximum 
intensity projection of MRI FLASH 3D sequence for imaging of blood vessels. AlbuminGd-DTPA was 
used as an MRI contrast agent.  
μ90 m μ90 m 3 mm
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Correlation of vascular structural and functional parameters measured by CLSM and  
DCE-MRI 
The structural parameters and permeability estimated by CLSM and DCE-MRI were 
plotted and compared, and linear regression was applied to the data (Fig. 4). A high 
degree of positive correlation (P < 0.001) was found between all structural vascular 
parameters, demonstrating a linear relationship between fractal dimension (D), vascular 
density (VD), fork density (FD), and vascular volume fraction (VVF). These structural 
parameters were significantly higher in tumors than in normal tissue, which can be 
observed from the two distinct populations in Fig. 4A-C. Extravasation measured by 
CLSM and represented by the extravasation rate Ki correlated (Pb0.02) with 
microvascular structure (Fig 4D-F). Ktrans estimated from DCE-MRI was shown to 
correlate (Pb0.05) with Ki and the initial slope of the extravascular fluorescence 
intensity-time curves, which were both used to estimate vascular extravasation (Fig. 4G 
and I). However, no correlation was found between Ktrans and apparent permeability P
which relates Ki to the vascular surface area. TTP represents the tissue uptake of 
Gadomer and was calculated from the DCE-MRI concentration-time curves. TTP was 
shown to correlate well with the initial slope of the extravascular fluorescence intensity 
curves (Fig. 4J), demonstrating similar accumulation kinetics for the two tracers. 
Mean values and standard deviations of all measurements in tumor and normal tissue 
are listed in Table 1, whereas the plots in Fig. 4 show mean values calculated from 1 – 3 
measurements at different locations in the tissue of each mouse. For the DCE-MRI data, 
only one ROI per animal was analyzed due to limited signal-to-noise ratio (SNR). The 
vascular structure demonstrated a high degree of heterogeneity within the same tumors, 
as indicated by large standard deviations in Fig. 4. Especially the extravasation rate 
showed large variations at the three measured locations, with the highest coefficient of 
variation (standard deviation/mean) of 2.43 for an animal, and the heterogeneity was 
larger within a tumor than between different mice (0.42) as estimated by the coefficients 
of variation. 
16 Reitan et al. Characterization of tumor microvascular structure and permeability: comparison between MRI and intravital confocal imaging
Extravasation rate, Ki (10
4 s-1)
-0,2 0,0 0,2 0,4 0,6 0,8
Fr
ac
ta
l d
im
en
si
on
, D
1,55
1,60
1,65
1,70
1,75
1,80
1,85
Ktrans (104 s-1)
3 4 5 6 7
Ex
tra
va
sa
tio
n 
ra
te
, K
i
(1
04
 s
-1
)
0,0
0,2
0,4
0,6
0,8
Extravasation rate, Ki (10
4 s-1)
-0,2 0,0 0,2 0,4 0,6 0,8
Va
sc
ul
ar
 d
en
si
ty
, V
D
0,20
0,25
0,30
0,35
0,40
0,45
0,50
0,55
0,60
Extravasation rate, Ki (10
4 s-1)
-0,2 0,0 0,2 0,4 0,6 0,8
Va
sc
ul
ar
 v
ol
um
e 
fra
ct
io
n,
 V
VF
0,05
0,10
0,15
0,20
0,25
0,30
0,35
R2=0,93
P=0,04
R2=0,88
P=0,02
R2=0,95
P=0,004
R2=0,86
P=0,02
Ktrans (104 s-1)
3 4 5 6 7Ap
pa
re
nt
 p
er
m
ea
bi
lit
y,
 P
(1
07
 c
m
-1
s-
1 )
0
2
4
6 R
2=0,24
P=0,51
Ktrans (104 s-1)
3 4 5 6 7
N
or
m
al
iz
ed
 in
iti
al
 s
lo
pe
 (s
-1
)
5
10
15
20
25
30
R2=0,79
P=0,04
Time to peak (s)
4,0 4,5 5,0 5,5 6,0 6,5 7,0
N
or
m
al
iz
ed
 in
iti
al
 s
lo
pe
 (s
-1
)
0
5
10
15
20
25
30
R2=0,94
P=0,007
(D) (E) (F)
(G) (H) (I)
(J)
Fractal dimension, D
1,5 1,6 1,7 1,8
Va
sc
ul
ar
 d
en
si
ty
, V
D
0,0
0,1
0,2
0,3
0,4
0,5
0,6
Fractal dimension, D
1,5 1,6 1,7 1,8
Fo
rk
 d
en
si
ty
, F
D
0
50
100
150
200
250
300
350
Fractal dimension, D
1,5 1,6 1,7 1,8
Va
sc
ul
ar
 v
ol
um
e 
fra
ct
io
n,
 V
VF
0,00
0,05
0,10
0,15
0,20
0,25
0,30
0,35
R2=0,97
P<0,0001
R2=0,68
P=0,0003
R2=0,95
P<0,0001
(A) (B) (C)
Figure 4. Correlation between vascular structural parameters and permeability obtained with CLSM and 
DCE-MRI. Microvascular structure: fractal dimension D, vascular density VD, fork density FD, and 
vascular volume VVF was measured by CLSM for normal (• ) and tumor tissue (9 ). Permeability 
parameters measured by CLSM (extravasation rate Ki, apparent permeability P, and initial slope) and 
DCE-MRI (Ktrans and time-to-peak TTP post-contrast) were plotted for tumor tissue. (A-C): Fractal 
dimension D plotted against structural parameters. (D-F): Permeability represented by the extravasation 
rate Ki versus structural parameters. (G-I) Ktrans obtained from DCE-MRI versus permeability parameters 
measured by CLSM. (J): TTP in DCE-MRI concentration-time curves versus the initial slope in CLSM 
intensity curves. Mean values and standard deviations are based on measurements in 1 – 3 ROIs. The 
goodness of linear fit R2 and the P-values are given in each plot. 
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Table 1. Estimates of permeability and microvasculature parameters in tumor and 
normal tissue in dorsal skinfold chambers.* 
CLSM parameters Tumor Normal  
Fractal dimension D 1.72 ±  0.06 1.59 ±  0.05 
Vascular density VD 0.38 ±  0.09 0.24 ±  0.06 
Fork density FD 144.0 ±  72.8 52.7 ±  20.3 
Vascular volume fraction VVF 0.20 ±  0.05 0.10 ±  0.03 
S/V (cm-1) 151.38 ±  40.92 95.70 ±  25.88 
Normalized initial slope (s-1) 15.4 ±  2.13  15.2 ±  2.58 
Extravasation rate Ki ( 4 110 s ) 0.42 ±  0.27 ** 
Apparent permeability P ( 7 1 110 cm s  ) 2.58 ±  1.95 ** 
DCE-MRI parameters Tumor Normal
Volume transfer constant Ktrans ( 4 110 s ) 5.02 ±  1.71 8.28 ±  3.32 
EES volume fraction ve 0.20 ±  0.04 0.20 ±  0.06 
Time-to-peak TTP (s) 6.23 ±  1.28  6.55 ±  1.63 
*   CLSM parameters are represented by mean values and standard deviations based on 4 – 9 mice and  
 1 – 3 measurements per mice. The mean DCE-MRI parameters are based on one measurement in  
 each of 5 mice. 
** The curves showed clear difference between tumor and normal tissue, but the numbers for normal  
 tissue were excluded because of a negative terminal slope in the Patlak plots.
Discussion
Tumor tissue is often characterized by abnormal microvascular structure and increased 
vascular permeability. These properties may predict therapeutic response. Robust 
methods are therefore required for quantifying the structural and functional parameters 
in tumor tissue. In the present study correlation between microvascular structure and 
permeability was found in OHS tumor tissue growing in dorsal window chambers 
imaged by CLSM and DCE-MRI. Few previous studies have directly related 
permeability of tumor vessels to its microvascular structure by applying these 
techniques in combination.31
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MRI provides non-invasive images of vasculature and is a technique of clinical 
importance in diagnosis and in monitoring therapeutic outcome. However, the spatial 
resolution in MRI is limited and confocal imaging provides an opportunity to obtain 
detailed information about microvasculature which is not accessible with MRI. In the 
present study, larger vessels were clearly observed using MRI whereas small capillaries 
and their branching pattern were visualized using CLSM. CLSM thus provide more 
detailed information about local variations than MRI. 
Choice of molecular tracers 
Gadomer was chosen as an MRI contrast agent because it is biocompatible, has 
previously been shown to provide information about vascular permeability,18,30,32,33 and 
has a suitable size for the present experiments. Gadomer could not be fluorescently 
labeled because all amines were occupied by Gd. A similar-sized, well-characterized 
dextran was therefore chosen as a fluorescent counterpart to Gadomer. Multi-modal 
macromolecular contrast agents, e.g. AlbuminGD-DTPA, were considered but they are 
generally larger than requested in this study.
Dextrans have previously been used to study permeability in tumors growing in dorsal 
window chambers. Dreher et al. used dextrans of various molecular weights (3.3 kDa – 
2 MDa) and showed that accumulation was maximal for dextrans with molecular 
weights between 40 and 70 kDa,9 indicating that the enhanced permeability effect is 
relevant for the chosen molecular tracers in the present study. 40 kDa dextran has also 
previously been used to characterize permeability of the capillaries in tumors growing in 
dorsal window chambers.27
Permeability estimated by CLSM and DCE-MRI 
Permeability of 40 kDa dextran was measured by acquiring CLSM time series. 
Measurements were performed in three different ROIs for each animal. All 
extravascular fluorescence-intensity curves showed an initial increase before the 
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intensity stabilized and occasionally decreased, probably due to reabsorbance into the 
vascular space or oozing out of the tumor due to the outward connective gradient. There 
were large variations in the time development and the maximum value of the intensity, 
both within a given tumor and between different animals, demonstrating a 
heterogeneous permeability. The spatial heterogeneity of extravasation in tumors is well 
known and is due to heterogeneous blood supply and anatomic variations of the tumor 
vessels.22,34,35 The correlation between functional and anatomic heterogeneity has been 
demonstrated by Dvorak et al., who showed that different types of vessels exhibit 
different degree of leakiness.35
Permeability of Gadomer was estimated from DCE-MRI measurements. The time 
development of the concentration curves obtained in the present study was consistent 
with previously found contrast uptake curves of Gadomer.30 The steep initial slope 
indicates high vascular permeability. The fast initial decay of the curves indicates that 
Gadomer is being efficiently cleared from plasma by glomerular filtration, resulting in a 
low concentration of Gadomer in the tissue, which is consistent with a low maximum 
value of the concentration curve.   
For kinetic analysis of the CLSM images, the method developed by Patlak et al.26 was 
chosen, whereas the DCE-MR images were analyzed by the well established two-
compartment kinetic model developed by Toft et al.19 Previously measured arterial 
input constants30 provided acceptable fit to the present DCE-MRI data. The Patlak 
method used to analyze CLSM data is based on the measured fluorescence intensity 
values, and does not require various input parameters such as the arterial input function. 
The method also avoids the use of complex pharmacokinetic modeling. Clear 
differences between normal and tumor tissue were observed for permeability estimated 
by the Patlak model. A negative terminal slope was observed in the Patlak plots for 
normal tissue, which indicates a rapid elimination of the tracer in the interstitium. No 
significant differences between tumors and normal tissue were detected from the DCE-
MRI data using the Tofts model.  
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The fact that CLSM could discriminate between tumor and normal tissue, whereas 
DCE-MRI could not, may be explained by differences in the methods, data analysis, 
and/or molecular tracers. Whereas dextran has a linear molecular structure and is 
neutral, Gadomer is globular and negatively charged. Permeability has previously been 
shown to depend on both molecular structure and charge.10,16 The image resolution used 
with CLSM (0.9 × 0.9 2mμ ) was superior to that of DCE-MRI (578 × 578 2mμ ).
Furthermore, the tissue in the dorsal window chamber was thin ( 0.5 mm for tumors, < 
0.5 mm for normal tissue). The SNR in images acquired with DCE-MRI was therefore 
low, and to maximize the SNR we chose to use the whole volume with detectable signal 
enhancement as ROI. The smaller ROIs used in CLSM ( 0.5 × 0.5 2mm ) may have 
been better suited to resolve the differences between tumors and normal tissue. The 
large ROIs used in DCE-MRI analysis may also have included normal vessels and 
thereby underestimated tumor permeability. To use smaller ROIs for analyzing DCE-
MRI data, e.g. pixel-based DCE-MRI, would be desirable but requires a higher SNR. 
Correlation between CLSM  and DCE-MRI 
The positive correlation obtained between Ktrans of Gadomer measured by DCE-MRI 
and the extravasation rate Ki of the 40 kDa dextran measured by CLSM demonstrated 
that extravasation measured by the two methods reflected each other even though 
different molecules and different mathematical models were used. Ki indicates the 
degree of accumulation of the tracer in the extravascular space, and is dependent on the 
available vasculature in the ROI. Therefore the apparent permeability per vascular 
surface area P was calculated by estimating the total vascular surface area in the tissue 
volume (S/V). However, P did not correlate with structural parameters (data not shown) 
or with Ktrans (Fig. 4H). This was unexpected and may be because S/V was not well-
defined in the optical section, as the optical section was thinner than the diameters of 
most vessels. In another study of extravasation of 40 kDa dextran in tumors using the 
dorsal window chamber model, Reyes-Aldasoro et al. analyzed 3D multi-photon images 
with the Patlak Model.27 3D images of one ROI may provide a more well-defined 
vascular surface area. However, in the present work we aimed to study the 
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heterogeneity within the vasculature by measuring three different ROIs. The time series 
required a high time resolution due to relatively fast extravasation, and we therefore 
chose to apply 2D imaging of several ROIs instead of 3D acquisition of one ROI.
Quantitative data for permeability was not the main focus of the present work and 
would have required thoroughly calibration of e.g. concentration versus intensity. We 
rather focused on relating information obtained from different techniques and analysis. 
Permeability was therefore also estimated from CLSM images by extracting the initial 
slope of the extravascular fluorescence intensity curve. There was a significant 
correlation between permeability estimated by the initial slope and the DCE-MRI 
parameters Ktrans and TTP. This indicates that a variety of relevant parameters may be 
applied in complementary CLSM and MRI analysis. 
The relation between microvascular structure and permeability 
Enhanced permeability in tumors is related to structural characteristics. The CLSM 
images revealed several structural parameters which were found to correlate with each 
other and with the estimated extravasation of dextran. Also, significant differences were 
found between the microvascular structure of tumors and normal tissue. 
Fractal analysis provides an overall mathematical description of the vascular network, 
and may reflect the degree of vascular tortuousity or self-similarity. The formation of 
new blood vessels in a tumor by angiogenesis is essential for tumor growth and 
metastasis, and the fractal dimension has been shown to yield information about 
vascular architecture, tumor growth and angiogenesis.13 The fractal dimension in the 
present study was 1.1 times higher for tumor vessels than for normal vessels. The same 
ratio between tumor and normal vessels was found by Gazit et al., although their fractal 
dimensions were somewhat higher (1.88 for tumors and 1.70 for normal arteriovenous 
vascular network).15 However, they determined the fractal dimension for normal 
capillaries to 1.99. The fractal dimension for normal tissue (1.59) calculated in the 
present study indicates that the investigated vasculature contained various vessel types 
22 Reitan et al. Characterization of tumor microvascular structure and permeability: comparison between MRI and intravital confocal imaging
and not only capillaries. The mean fractal dimensions correlated positively with 
extravasation rate, vascular density, fork density, and vascular volume fraction, which 
all may be potential indicators of angiogenetic activity.
Vascular parameters such as microvessel density and permability may be prognostic 
factors, and has been shown to predict outcome in patients with breast, colon, and lung 
cancer.36-40 Anti-angiogenic therapy blocking the vascular endothelial growth factor 
(VEGF) or its receptor (VEGFR2) is reported to induce apoptosis in the endothelial 
cells and decrease the vessel diameter, density, and permeability41,42. These changes 
were accompanied by the development of a normal phenotype of the vessel structure, 
and this normalization of the vascular structure resulted in decreased interstitial fluid 
pressure and a more normal microenvironment. The normalization of the vasculature 
and the reduced interstitial fluid pressure may facilitate drug delivery. There is a need to 
find reliable biomarkers reflecting the vascular structure and thereby the prognostic 
outcome. Vascular permeability may be such a marker, and Ktrans is reported to be 
uniquely suited to evaluate the normalization process in tumor vasculature.43. The 
present work demonstrates that MRI and CLSM may be useful complementary methods 
in the characterization of permeability.  
Conclusion
By combining CLSM and DCE-MRI we measured permeability and microvascular 
architecture in tumors growing in dorsal window chambers in mice. A correlation was 
found between permeability parameters estimated by the two techniques. Permeability 
was further shown to depend on structural parameters, like fractal dimension, vascular 
volume fraction, and vascular density. We have demonstrated that the dorsal window 
tumor model gives a unique opportunity to use CLSM and MRI as complementary 
techniques. CLSM can both validate results obtained with MRI and provide insight into 
the spatial heterogeneous microenvironment on a microscopic level which is not 
accessible with MRI.  
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